1 | Final results of a phase 1b study of isatuximab short-duration fixed-volume infusion combination therapy for relapsed/refractory multiple myeloma. (Usmani SZ, Karanes C, Bensinger WI, D'Souza A, Raje N, Tuchman SA, Sborov D, Laubach JP, Bianchi G, Kanagavel D, Saleem R, Dubin F, Campana F, Richardson PG) Leukemia 2021 Dec;35(12):3526-3533 12 Citations |
1 | Phase II study of pazopanib with oral topotecan in patients with metastatic and non-resectable soft tissue and bone sarcomas. (Schulte B, Mohindra N, Milhem M, Attia S, Robinson S, Monga V, Hirbe AC, Oppelt P, Charlson J, Helenowski I, Abbinanti S, Cehic R, Okuno S, Van Tine BA, Agulnik M) Br J Cancer 2021 Aug;125(4):528-533 11 Citations |
1 | Camidanlumab tesirine in patients with relapsed or refractory lymphoma: a phase 1, open-label, multicentre, dose-escalation, dose-expansion study. (Hamadani M, Collins GP, Caimi PF, Samaniego F, Spira A, Davies A, Radford J, Menne T, Karnad A, Zain JM, Fields P, Havenith K, Cruz HG, He S, Boni J, Feingold J, Wuerthner J, Horwitz S) Lancet Haematol 2021 Jun;8(6):e433-e445 47 Citations |
1 | Preoperative Management of Opioid and Nonopioid Analgesics: Society for Perioperative Assessment and Quality Improvement (SPAQI) Consensus Statement. (O'Rourke MJ, Keshock MC, Boxhorn CE, Correll DJ, O'Glasser AY, Gazelka HM, Urman RD, Mauck K) Mayo Clin Proc 2021 May;96(5):1325-1341 12 Citations |
1 | Bimekizumab efficacy and safety in moderate to severe plaque psoriasis (BE READY): a multicentre, double-blind, placebo-controlled, randomised withdrawal phase 3 trial. (Gordon KB, Foley P, Krueger JG, Pinter A, Reich K, Vender R, Vanvoorden V, Madden C, White K, Cioffi C, Blauvelt A) Lancet 2021 Feb 06;397(10273):475-486 118 Citations |
1 | Sequencing of novel agents in relapsed/refractory B-cell acute lymphoblastic leukemia: Blinatumomab and inotuzumab ozogamicin may have comparable efficacy as first or second novel agent therapy in relapsed/refractory acute lymphoblastic leukemia. (Badar T, Szabo A, Dinner S, Liedtke M, Burkart M, Shallis RM, Yurkiewicz IR, Kuo E, Khan MA, Balasubramanian S, Yang J, Hefazi M, Podoltsev N, Patel A, Curran E, Wang A, Arslan S, Aldoss I, Siebenaller C, Mattison RJ, Litzow MR, Wadleigh M, Advani AS, Atallah E) Cancer 2021 Apr 01;127(7):1039-1048 16 Citations |
1 | Flotetuzumab as salvage immunotherapy for refractory acute myeloid leukemia. (Uy GL, Aldoss I, Foster MC, Sayre PH, Wieduwilt MJ, Advani AS, Godwin JE, Arellano ML, Sweet KL, Emadi A, Ravandi F, Erba HP, Byrne M, Michaelis L, Topp MS, Vey N, Ciceri F, Carrabba MG, Paolini S, Huls GA, Jongen-Lavrencic M, Wermke M, Chevallier P, Gyan E, Récher C, Stiff PJ, Pettit KM, Löwenberg B, Church SE, Anderson E, Vadakekolathu J, Santaguida M, Rettig MP, Muth J, Curtis T, Fehr E, Guo K, Zhao J, Bakkacha O, Jacobs K, Tran K, Kaminker P, Kostova M, Bonvini E, Walter RB, Davidson-Moncada JK, Rutella S, DiPersio JF) Blood 2021 Feb 11;137(6):751-762 177 Citations |
1 | Persistent Hyperinsulinemia Following High-Dose Insulin Therapy: A Case Report. (Corcoran JN, Jacoby KJ, Olives TD, Bangh SA, Cole JB) J Med Toxicol 2020 Oct;16(4):465-469 9 Citations |
2 | The association between timely opioid administration and hospitalization in children with sickle cell disease presenting to the emergency department in acute pain. (Muslu CS, Kopetsky M, Nimmer M, Visotcky A, Fraser R, Brousseau DC) Pediatr Blood Cancer 2020 Sep;67(9):e28268 3 Citations |
1 | Pharmacokinetics of Oral Treprostinil in Children With Pulmonary Arterial Hypertension. (Hopper RK, Ivy DD, Yung D, Mullen MP, Hanna BD, Kirkpatrick E, Hirsch R, Austin ED, Fineman J, Solum D, Deng CQ, Feinstein JA) J Cardiovasc Pharmacol 2020 Jul;76(1):94-100 1 Citation |
1 | Use of a Porcine Model to Evaluate the Risks and Benefits of Vasopressors in Propranolol Poisoning. (Cole JB, Corcoran JN, Engebretsen KM, Stellpflug SJ) J Med Toxicol 2020 Apr;16(2):212-221 8 Citations |
1 | Transcatheter aortic valve replacement thrombosis in patient supported with durable left ventricular assist device. (Rao SD, Jagasia D, Anwaruddin S, Birati EY) Catheter Cardiovasc Interv 2020 Aug;96(2):500-503 8 Citations |
1 | Teprotumumab for the Treatment of Active Thyroid Eye Disease. (Douglas RS, Kahaly GJ, Patel A, Sile S, Thompson EHZ, Perdok R, Fleming JC, Fowler BT, Marcocci C, Marinò M, Antonelli A, Dailey R, Harris GJ, Eckstein A, Schiffman J, Tang R, Nelson C, Salvi M, Wester S, Sherman JW, Vescio T, Holt RJ, Smith TJ) N Engl J Med 2020 Jan 23;382(4):341-352 357 Citations |
3 | Complicated Appendicitis: Are Extended Antibiotics Necessary? A Post Hoc Analysis of the EAST Appendicitis "MUSTANG" Study. (Bou Zein Eddine S, Dodgion CM, Qian S, Trevino C, De Moya MA, Yeh DD, EAST Appendicitis Research Group) J Surg Res 2020 Mar;247:508-513 9 Citations |
2 | Results of the FUEL Trial. (Goldberg DJ, Zak V, Goldstein BH, Schumacher KR, Rhodes J, Penny DJ, Petit CJ, Ginde S, Menon SC, Kim SH, Kim GB, Nowlen TT, DiMaria MV, Frischhertz BP, Wagner JB, McHugh KE, McCrindle BW, Shillingford AJ, Sabati AA, Yetman AT, John AS, Richmond ME, Files MD, Payne RM, Mackie AS, Davis CK, Shahanavaz S, Hill KD, Garg R, Jacobs JP, Hamstra MS, Woyciechowski S, Rathge KA, McBride MG, Frommelt PC, Russell MW, Urbina EM, Yeager JL, Pemberton VL, Stylianou MP, Pearson GD, Paridon SM, Pediatric Heart Network Investigators) Circulation 2020 Feb 25;141(8):641-651 81 Citations |
1 | Antibiotic Duration and Outcome Complications for Surgical Site Infection Prevention in Traumatic Mandible Fracture. (Zein Eddine SB, Cooper-Johnson K, Ericksen F, Brookes CC, Peppard WJ, Revolinski SL, Carver TW) J Surg Res 2020 Mar;247:524-529 9 Citations |
1 | Rituximab or Cyclosporine in the Treatment of Membranous Nephropathy. (Fervenza FC, Appel GB, Barbour SJ, Rovin BH, Lafayette RA, Aslam N, Jefferson JA, Gipson PE, Rizk DV, Sedor JR, Simon JF, McCarthy ET, Brenchley P, Sethi S, Avila-Casado C, Beanlands H, Lieske JC, Philibert D, Li T, Thomas LF, Green DF, Juncos LA, Beara-Lasic L, Blumenthal SS, Sussman AN, Erickson SB, Hladunewich M, Canetta PA, Hebert LA, Leung N, Radhakrishnan J, Reich HN, Parikh SV, Gipson DS, Lee DK, da Costa BR, Jüni P, Cattran DC, MENTOR Investigators) N Engl J Med 2019 Jul 04;381(1):36-46 298 Citations |
1 | American Society for Enhanced Recovery and Perioperative Quality Initiative Joint Consensus Statement on Perioperative Opioid Minimization in Opioid-Naïve Patients. (Wu CL, King AB, Geiger TM, Grant MC, Grocott MPW, Gupta R, Hah JM, Miller TE, Shaw AD, Gan TJ, Thacker JKM, Mythen MG, McEvoy MD, Fourth Perioperative Quality Initiative Workgroup) Anesth Analg 2019 Aug;129(2):567-577 79 Citations |
1 | Development of an Antibiotic Guideline for Children With Suspected Ventilator-Associated Infections. (Shein SL, Karam O, Beardsley A, Karsies T, Prentice E, Tarquinio KM, Willson DF, Pediatric Acute Lung Injury and Sepsis Investigator (PALISI) Network) Pediatr Crit Care Med 2019 Aug;20(8):697-706 7 Citations |
1 | American Society for Enhanced Recovery and Perioperative Quality Initiative-4 Joint Consensus Statement on Persistent Postoperative Opioid Use: Definition, Incidence, Risk Factors, and Health Care System Initiatives. (Kent ML, Hurley RW, Oderda GM, Gordon DB, Sun E, Mythen M, Miller TE, Shaw AD, Gan TJ, Thacker JKM, McEvoy MD, POQI-4 Working Group) Anesth Analg 2019 Aug;129(2):543-552 89 Citations |
1 | American Society for Enhanced Recovery and Perioperative Quality Initiative Joint Consensus Statement on Perioperative Management of Patients on Preoperative Opioid Therapy. (Edwards DA, Hedrick TL, Jayaram J, Argoff C, Gulur P, Holubar SD, Gan TJ, Mythen MG, Miller TE, Shaw AD, Thacker JKM, McEvoy MD, POQI-4 Working Group) Anesth Analg 2019 Aug;129(2):553-566 61 Citations |
1 | Efficacy and safety of ruzasvir 60 mg and uprifosbuvir 450 mg for 12 weeks in adults with chronic hepatitis C virus genotype 1, 2, 3, 4 or 6 infection. (Lawitz E, Poordad F, Anderson LJ, Vesay M, Kelly MM, Liu H, Gao W, Fernsler D, Asante-Appiah E, Robertson MN, Hanna GJ, Barr E, Butterton J, Kowdley KV, Hassanein T, Sahota A, Gordon SC, Yeh WW) J Viral Hepat 2019 Jun;26(6):675-684 4 Citations |
1 | Influence of preoperative opioid use on postoperative outcomes and opioid use after arthroscopic rotator cuff repair. (Williams BT, Redlich NJ, Mickschl DJ, Grindel SI) J Shoulder Elbow Surg 2019 Mar;28(3):453-460 48 Citations |
1 | Is Long-Term Anticoagulation Required after Stent Placement for Benign Superior Vena Cava Syndrome? (Haddad MM, Thompson SM, McPhail IR, Bendel EC, Kalra M, Stockland AH, Neidert NB, Andrews JC, Misra S, Bjarnason H, Neisen MJ) J Vasc Interv Radiol 2018 Dec;29(12):1741-1747 15 Citations |
1 | Inhibition of Cytomegalovirus Replication with Extended-Half-Life Synthetic Ozonides. (Wang Y, Mukhopadhyay R, Roy S, Kapoor A, Su YP, Charman SA, Chen G, Wu J, Wang X, Vennerstrom JL, Arav-Boger R) Antimicrob Agents Chemother 2019 Jan;63(1) 11 Citations |
1 | Sequence of hormonal therapy and radiotherapy field size in unfavourable, localised prostate cancer (NRG/RTOG 9413): long-term results of a randomised, phase 3 trial. (Roach M, Moughan J, Lawton CAF, Dicker AP, Zeitzer KL, Gore EM, Kwok Y, Seider MJ, Hsu IC, Hartford AC, Horwitz EM, Yamoah K, Jones CU, Michalski JM, Lee WR, Pisansky TM, Rabinovitch R, Rotman M, Pryzant RM, Kim HE, Thomas CR Jr, Shipley WU, Sandler HM) Lancet Oncol 2018 Nov;19(11):1504-1515 157 Citations |
1 | Phase 2 Trial of Selective Tyrosine Kinase 2 Inhibition in Psoriasis. (Papp K, Gordon K, Thaçi D, Morita A, Gooderham M, Foley P, Girgis IG, Kundu S, Banerjee S) N Engl J Med 2018 Oct 04;379(14):1313-1321 264 Citations |
1 | Renal Revival: The Hidden Benefit of Antirejection Medications. (Koratala A, Kazory A) Transplantation 2018 Nov;102(11):e481-e482 |
1 | Phase I Study To Evaluate the Pharmacokinetics, Safety, and Tolerability of Two Dosing Regimens of Oral Fosfomycin Tromethamine in Healthy Adult Participants. (Wenzler E, Bleasdale SC, Sikka M, Bunnell KL, Finnemeyer M, Rosenkranz SL, Danziger LH, Rodvold KA, Antibacterial Resistance Leadership Group) Antimicrob Agents Chemother 2018 Aug;62(8) 26 Citations |
1 | Rivaroxaban for thromboprophylaxis among patients recently hospitalized for acute infectious diseases: a subgroup analysis of the MAGELLAN study. (Cohoon KP, De Sanctis Y, Haskell L, McBane RD, Spiro TE) J Thromb Haemost 2018 Jul;16(7):1278-1287 22 Citations |
1 | Anxiety and depression in patients with moderate-to-severe psoriasis and comparison of change from baseline after treatment with guselkumab vs. adalimumab: results from the Phase 3 VOYAGE 2 study. (Gordon KB, Armstrong AW, Han C, Foley P, Song M, Wasfi Y, You Y, Shen YK, Reich K) J Eur Acad Dermatol Venereol 2018 Nov;32(11):1940-1949 59 Citations |
1 | Phase I study of nab-paclitaxel, gemcitabine, and bevacizumab in patients with advanced cancers. (Sen S, Kato S, Agarwal R, Piha-Paul S, Hess K, Karp D, Janku F, Fu S, Naing A, Pant S, Falchook G, Tang C, Wu X, Ye Y, Tsimberidou A, Subbiah V, Kurzrock R, Byers L, Westin S, Lim J, Bean S, Bass A, Nguyen L, Meric-Bernstam F, Hong D) Br J Cancer 2018 May;118(11):1419-1424 6 Citations |
1 | Long-term optimization of outcomes with flexible adalimumab dosing in patients with moderate to severe plaque psoriasis. (Gniadecki R, Leonardi CL, Gordon KB, Gu Y, Geng Z, Nader A, Teixeira HD) J Eur Acad Dermatol Venereol 2018 Aug;32(8):1297-1304 9 Citations |
1 | Comparison of Monthly vs Treat-and-Extend Regimens for Individuals With Macular Edema Who Respond Well to Anti-Vascular Endothelial Growth Factor Medications: Secondary Outcomes From the SCORE2 Randomized Clinical Trial. (Scott IU, VanVeldhuisen PC, Ip MS, Blodi BA, Oden NL, Altaweel M, Berinstein DM, SCORE2 Investigator Group) JAMA Ophthalmol 2018 Apr 01;136(4):337-345 29 Citations |
1 | Dasatinib dose management for the treatment of chronic myeloid leukemia. (Talpaz M, Saglio G, Atallah E, Rousselot P) Cancer 2018 Apr 15;124(8):1660-1672 18 Citations |
1 | Anticoagulant prophylaxis and therapy in children: current challenges and emerging issues. (Newall F, Branchford B, Male C) J Thromb Haemost 2018 Feb;16(2):196-208 32 Citations |
1 | Effects of Intensive Blood Pressure Treatment on Acute Kidney Injury Events in the Systolic Blood Pressure Intervention Trial (SPRINT). (Rocco MV, Sink KM, Lovato LC, Wolfgram DF, Wiegmann TB, Wall BM, Umanath K, Rahbari-Oskoui F, Porter AC, Pisoni R, Lewis CE, Lewis JB, Lash JP, Katz LA, Hawfield AT, Haley WE, Freedman BI, Dwyer JP, Drawz PE, Dobre M, Cheung AK, Campbell RC, Bhatt U, Beddhu S, Kimmel PL, Reboussin DM, Chertow GM, SPRINT Research Group) Am J Kidney Dis 2018 Mar;71(3):352-361 104 Citations |
1 | Phase II randomised discontinuation trial of cabozantinib in patients with advanced solid tumours. (Schöffski P, Gordon M, Smith DC, Kurzrock R, Daud A, Vogelzang NJ, Lee Y, Scheffold C, Shapiro GI) Eur J Cancer 2017 Nov;86:296-304 58 Citations |
1 | Effect of Inhaled Nitric Oxide on Survival Without Bronchopulmonary Dysplasia in Preterm Infants: A Randomized Clinical Trial. (Hasan SU, Potenziano J, Konduri GG, Perez JA, Van Meurs KP, Walker MW, Yoder BA, Newborns Treated With Nitric Oxide (NEWNO) Trial Group) JAMA Pediatr 2017 Nov 01;171(11):1081-1089 49 Citations |
1 | Impact of Procalcitonin Guidance with an Educational Program on Management of Adults Hospitalized with Pneumonia. (Walsh TL, DiSilvio BE, Hammer C, Beg M, Vishwanathan S, Speredelozzi D, Moffa MA, Hu K, Abdulmassih R, Makadia JT, Sandhu R, Naddour M, Chan-Tompkins NH, Trienski TL, Watson C, Obringer TJ, Kuzyck J, Bremmer DN) Am J Med 2018 Feb;131(2):201.e1-201.e8 17 Citations |
1 | Efficacy of guselkumab in subpopulations of patients with moderate-to-severe plaque psoriasis: a pooled analysis of the phase III VOYAGE 1 and VOYAGE 2 studies. (Gordon KB, Blauvelt A, Foley P, Song M, Wasfi Y, Randazzo B, Shen YK, You Y, Griffiths CEM) Br J Dermatol 2018 Jan;178(1):132-139 60 Citations |
1 | Intraoperative ketamine for prevention of postoperative delirium or pain after major surgery in older adults: an international, multicentre, double-blind, randomised clinical trial. (Avidan MS, Maybrier HR, Abdallah AB, Jacobsohn E, Vlisides PE, Pryor KO, Veselis RA, Grocott HP, Emmert DA, Rogers EM, Downey RJ, Yulico H, Noh GJ, Lee YH, Waszynski CM, Arya VK, Pagel PS, Hudetz JA, Muench MR, Fritz BA, Waberski W, Inouye SK, Mashour GA, PODCAST Research Group) Lancet 2017 Jul 15;390(10091):267-275 305 Citations |
1 | Effect of diltiazem on exercise capacity after heart transplantation. (Varnado S, Peled-Potashnik Y, Huntsberry A, Lowes BD, Zolty R, Burdorf A, Lyden ER, Moulton MJ, Um JY, Raichlin E) Clin Transplant 2017 Aug;31(8) 4 Citations |
1 | Management of adverse events associated with ixazomib plus lenalidomide/dexamethasone in relapsed/refractory multiple myeloma. (Kumar S, Moreau P, Hari P, Mateos MV, Ludwig H, Shustik C, Masszi T, Spencer A, Hájek R, Romeril K, Avivi I, Liberati AM, Minnema MC, Einsele H, Lonial S, Berg D, Lin J, Gupta N, Esseltine DL, Richardson PG) Br J Haematol 2017 Aug;178(4):571-582 55 Citations |
1 | Rapid Discontinuation of Prednisone in Kidney Transplant Recipients: 15-Year Outcomes From the University of Minnesota. (Serrano OK, Kandaswamy R, Gillingham K, Chinnakotla S, Dunn TB, Finger E, Payne W, Ibrahim H, Kukla A, Spong R, Issa N, Pruett TL, Matas A) Transplantation 2017 Oct;101(10):2590-2598 27 Citations |
1 | Ventricular assist device thrombosis: Mind your P's &Q's-Pumps, patients, and pills. (Massicotte P, Snyder T, Stulak J, Baumann Kreuziger L) J Thorac Cardiovasc Surg 2017 Jun;153(6):1503-1506 10 Citations |
1 | To use or not to use? Amiodarone before heart transplantation. (Lushaj EB, Dhingra R, Chindhy S, Akhter S, Kohmoto T, Ulschmid S, Osaki S, Badami A, Lozonschi L) Surgery 2017 May;161(5):1273-1278 12 Citations |
3 | Serotonin Syndrome Resulting From Acute Decompensation of Nonalcoholic Steatohepatitis Cirrhosis in a Patient Chronically Treated With Citalopram and Tramadol. (Gollapudy S, Cronin DC, Pagel PS, Boettcher BT) J Cardiothorac Vasc Anesth 2017 Aug;31(4):1385-1388 2 Citations |
1 | Pediatric Ventilator-Associated Infections: The Ventilator-Associated INfection Study. (Willson DF, Hoot M, Khemani R, Carrol C, Kirby A, Schwarz A, Gedeit R, Nett ST, Erickson S, Flori H, Hays S, Hall M, Ventilator-Associated INfection (VAIN) Investigators and the Pediatric Acute Lung Injury and Sepsis Investigator’s (PALISI) Network) Pediatr Crit Care Med 2017 Jan;18(1):e24-e34 22 Citations |
1 | Sodium nitroprusside enhanced cardiopulmonary resuscitation improves short term survival in a porcine model of ischemic refractory ventricular fibrillation. (Yannopoulos D, Bartos JA, George SA, Sideris G, Voicu S, Oestreich B, Matsuura T, Shekar K, Rees J, Aufderheide TP) Resuscitation 2017 Jan;110:6-11 15 Citations |
1 | Effect of Deutetrabenazine on Chorea Among Patients With Huntington Disease: A Randomized Clinical Trial. (Huntington Study Group, Frank S, Testa CM, Stamler D, Kayson E, Davis C, Edmondson MC, Kinel S, Leavitt B, Oakes D, O'Neill C, Vaughan C, Goldstein J, Herzog M, Snively V, Whaley J, Wong C, Suter G, Jankovic J, Jimenez-Shahed J, Hunter C, Claassen DO, Roman OC, Sung V, Smith J, Janicki S, Clouse R, Saint-Hilaire M, Hohler A, Turpin D, James RC, Rodriguez R, Rizer K, Anderson KE, Heller H, Carlson A, Criswell S, Racette BA, Revilla FJ, Nucifora F Jr, Margolis RL, Ong M, Mendis T, Mendis N, Singer C, Quesada M, Paulsen JS, Brashers-Krug T, Miller A, Kerr J, Dubinsky RM, Gray C, Factor SA, Sperin E, Molho E, Eglow M, Evans S, Kumar R, Reeves C, Samii A, Chouinard S, Beland M, Scott BL, Hickey PT, Esmail S, Fung WL, Gibbons C, Qi L, Colcher A, Hackmyer C, McGarry A, Klos K, Gudesblatt M, Fafard L, Graffitti L, Schneider DP, Dhall R, Wojcieszek JM, LaFaver K, Duker A, Neefus E, Wilson-Perez H, Shprecher D, Wall P, Blindauer KA, Wheeler L, Boyd JT, Houston E, Farbman ES, Agarwal P, Eberly SW, Watts A, Tariot PN, Feigin A, Evans S, Beck C, Orme C, Edicola J, Christopher E) JAMA 2016 Jul 05;316(1):40-50 160 Citations |
1 | Intravenous Busulfan-Based Myeloablative Conditioning Regimens Prior to Hematopoietic Cell Transplantation for Hematologic Malignancies. (Pasquini MC, Le-Rademacher J, Zhu X, Artz A, DiPersio J, Fernandez HF, Mineishi S, Kamishohara M, Mehta J, Nakamura Y, Ratanatharathorn V, Sobecks R, Burkart J, Bredeson C) Biol Blood Marrow Transplant 2016 Aug;22(8):1424-1430 15 Citations |
1 | Phase I clinical trial of lenalidomide in combination with bevacizumab in patients with advanced cancer. (Said R, Kakadiaris E, Piha-Paul S, Fu S, Falchook G, Janku F, Wheler JJ, Zinner R, Hong DS, Kurzrock R, Tsimberidou AM) Cancer Chemother Pharmacol 2016 May;77(5):1097-102 4 Citations |
1 | Vascular Effects of Early versus Late Postmenopausal Treatment with Estradiol. (Hodis HN, Mack WJ, Henderson VW, Shoupe D, Budoff MJ, Hwang-Levine J, Li Y, Feng M, Dustin L, Kono N, Stanczyk FZ, Selzer RH, Azen SP, ELITE Research Group) N Engl J Med 2016 Mar 31;374(13):1221-31 512 Citations |
1 | Rigosertib versus best supportive care for patients with high-risk myelodysplastic syndromes after failure of hypomethylating drugs (ONTIME): a randomised, controlled, phase 3 trial. (Garcia-Manero G, Fenaux P, Al-Kali A, Baer MR, Sekeres MA, Roboz GJ, Gaidano G, Scott BL, Greenberg P, Platzbecker U, Steensma DP, Kambhampati S, Kreuzer KA, Godley LA, Atallah E, Collins R Jr, Kantarjian H, Jabbour E, Wilhelm FE, Azarnia N, Silverman LR, ONTIME study investigators) Lancet Oncol 2016 Apr;17(4):496-508 138 Citations |
1 | Chronic Co-Administration of Sepiapterin and L-Citrulline Ameliorates Diabetic Cardiomyopathy and Myocardial Ischemia/Reperfusion Injury in Obese Type 2 Diabetic Mice. (Baumgardt SL, Paterson M, Leucker TM, Fang J, Zhang DX, Bosnjak ZJ, Warltier DC, Kersten JR, Ge ZD) Circ Heart Fail 2016 Jan;9(1):e002424 46 Citations |
1 | Phase II Study of Allogeneic Transplantation for Older Patients With Acute Myeloid Leukemia in First Complete Remission Using a Reduced-Intensity Conditioning Regimen: Results From Cancer and Leukemia Group B 100103 (Alliance for Clinical Trials in Oncology)/Blood and Marrow Transplant Clinical Trial Network 0502. (Devine SM, Owzar K, Blum W, Mulkey F, Stone RM, Hsu JW, Champlin RE, Chen YB, Vij R, Slack J, Soiffer RJ, Larson RA, Shea TC, Hars V, Sibley AB, Giralt S, Carter S, Horowitz MM, Linker C, Alyea EP) J Clin Oncol 2015 Dec 10;33(35):4167-75 125 Citations |
1 | Novel phase I study combining G1 phase, S phase, and G2/M phase cell cycle inhibitors in patients with advanced malignancies. (Jain RK, Hong DS, Naing A, Wheler J, Helgason T, Shi NY, Gad Y, Kurzrock R) Cell Cycle 2015;14(21):3434-40 6 Citations |
1 | Phase 3 Studies Comparing Brodalumab with Ustekinumab in Psoriasis. (Lebwohl M, Strober B, Menter A, Gordon K, Weglowska J, Puig L, Papp K, Spelman L, Toth D, Kerdel F, Armstrong AW, Stingl G, Kimball AB, Bachelez H, Wu JJ, Crowley J, Langley RG, Blicharski T, Paul C, Lacour JP, Tyring S, Kircik L, Chimenti S, Callis Duffin K, Bagel J, Koo J, Aras G, Li J, Song W, Milmont CE, Shi Y, Erondu N, Klekotka P, Kotzin B, Nirula A) N Engl J Med 2015 Oct;373(14):1318-28 643 Citations |
1 | A Phase IIb, Multicenter, Open-Label, Safety, and Efficacy Study of High-Dose, Propylene Glycol-Free Melphalan Hydrochloride for Injection (EVOMELA) for Myeloablative Conditioning in Multiple Myeloma Patients Undergoing Autologous Transplantation. (Hari P, Aljitawi OS, Arce-Lara C, Nath R, Callander N, Bhat G, Allen LF, Stockerl-Goldstein K) Biol Blood Marrow Transplant 2015 Dec;21(12):2100-2105 23 Citations |
1 | A phase 2, open-label, multicenter study of the long-term safety of siltuximab (an anti-interleukin-6 monoclonal antibody) in patients with multicentric Castleman disease. (van Rhee F, Casper C, Voorhees PM, Fayad LE, van de Velde H, Vermeulen J, Qin X, Qi M, Tromp B, Kurzrock R) Oncotarget 2015 Oct 06;6(30):30408-19 51 Citations |
1 | A phase 1 study of intermittently administered pazopanib in combination with continuous daily dosing of lapatinib in patients with solid tumors. (Henary H, George GC, Wheler J, Naing A, Piha-Paul S, Fu S, Mistry R, Zinner R, Kurzrock R, Hong DS) Cancer Chemother Pharmacol 2015 Sep;76(3):597-603 1 Citation |
1 | Safety and activity of BTK inhibitor ibrutinib combined with ofatumumab in chronic lymphocytic leukemia: a phase 1b/2 study. (Jaglowski SM, Jones JA, Nagar V, Flynn JM, Andritsos LA, Maddocks KJ, Woyach JA, Blum KA, Grever MR, Smucker K, Ruppert AS, Heerema NA, Lozanski G, Stefanos M, Munneke B, West JS, Neuenburg JK, James DF, Hall N, Johnson AJ, Byrd JC) Blood 2015 Aug 13;126(7):842-50 116 Citations |
1 | Gray zone lymphoma with features intermediate between classical Hodgkin lymphoma and diffuse large B-cell lymphoma: characteristics, outcomes, and prognostication among a large multicenter cohort. (Evens AM, Kanakry JA, Sehn LH, Kritharis A, Feldman T, Kroll A, Gascoyne RD, Abramson JS, Petrich AM, Hernandez-Ilizaliturri FJ, Al-Mansour Z, Adeimy C, Hemminger J, Bartlett NL, Mato A, Caimi PF, Advani RH, Klein AK, Nabhan C, Smith SM, Fabregas JC, Lossos IS, Press OW, Fenske TS, Friedberg JW, Vose JM, Blum KA) Am J Hematol 2015 Sep;90(9):778-83 71 Citations |
1 | Long-term use of ticagrelor in patients with prior myocardial infarction. (Bonaca MP, Bhatt DL, Cohen M, Steg PG, Storey RF, Jensen EC, Magnani G, Bansilal S, Fish MP, Im K, Bengtsson O, Oude Ophuis T, Budaj A, Theroux P, Ruda M, Hamm C, Goto S, Spinar J, Nicolau JC, Kiss RG, Murphy SA, Wiviott SD, Held P, Braunwald E, Sabatine MS, PEGASUS-TIMI 54 Steering Committee and Investigators) N Engl J Med 2015 May 07;372(19):1791-800 1582 Citations |
1 | Valganciclovir for symptomatic congenital cytomegalovirus disease. (Kimberlin DW, Jester PM, Sánchez PJ, Ahmed A, Arav-Boger R, Michaels MG, Ashouri N, Englund JA, Estrada B, Jacobs RF, Romero JR, Sood SK, Whitworth MS, Abzug MJ, Caserta MT, Fowler S, Lujan-Zilbermann J, Storch GA, DeBiasi RL, Han JY, Palmer A, Weiner LB, Bocchini JA, Dennehy PH, Finn A, Griffiths PD, Luck S, Gutierrez K, Halasa N, Homans J, Shane AL, Sharland M, Simonsen K, Vanchiere JA, Woods CR, Sabo DL, Aban I, Kuo H, James SH, Prichard MN, Griffin J, Giles D, Acosta EP, Whitley RJ, National Institute of Allergy and Infectious Diseases Collaborative Antiviral Study Group) N Engl J Med 2015 Mar 05;372(10):933-43 518 Citations |
3 | Impact of conditioning regimen on outcomes for patients with lymphoma undergoing high-dose therapy with autologous hematopoietic cell transplantation. (Chen YB, Lane AA, Logan B, Zhu X, Akpek G, Aljurf M, Artz A, Bredeson CN, Cooke KR, Ho VT, Lazarus HM, Olsson R, Saber W, McCarthy P, Pasquini MC) Biol Blood Marrow Transplant 2015 Jun;21(6):1046-1053 122 Citations |
1 | SU2C phase Ib study of paclitaxel and MK-2206 in advanced solid tumors and metastatic breast cancer. (Gonzalez-Angulo AM, Krop I, Akcakanat A, Chen H, Liu S, Li Y, Culotta KS, Tarco E, Piha-Paul S, Moulder-Thompson S, Velez-Bravo V, Sahin AA, Doyle LA, Do KA, Winer EP, Mills GB, Kurzrock R, Meric-Bernstam F) J Natl Cancer Inst 2015 Mar;107(3) 28 Citations |
1 | Phase I study of pazopanib and vorinostat: a therapeutic approach for inhibiting mutant p53-mediated angiogenesis and facilitating mutant p53 degradation. (Fu S, Hou MM, Naing A, Janku F, Hess K, Zinner R, Subbiah V, Hong D, Wheler J, Piha-Paul S, Tsimberidou A, Karp D, Araujo D, Kee B, Hwu P, Wolff R, Kurzrock R, Meric-Bernstam F) Ann Oncol 2015 May;26(5):1012-1018 52 Citations |
1 | Patterns of relapse from a phase 3 Study of response-based therapy for intermediate-risk Hodgkin lymphoma (AHOD0031): a report from the Children's Oncology Group. (Dharmarajan KV, Friedman DL, Schwartz CL, Chen L, FitzGerald TJ, McCarten KM, Kessel SK, Iandoli M, Constine LS, Wolden SL) Int J Radiat Oncol Biol Phys 2015 May 01;92(1):60-6 22 Citations |
1 | Very early administration of progesterone for acute traumatic brain injury. (Wright DW, Yeatts SD, Silbergleit R, Palesch YY, Hertzberg VS, Frankel M, Goldstein FC, Caveney AF, Howlett-Smith H, Bengelink EM, Manley GT, Merck LH, Janis LS, Barsan WG, NETT Investigators) N Engl J Med 2014 Dec 25;371(26):2457-66 427 Citations |
2 | Efficacy endpoints of radiation therapy group protocol 0247: a randomized, phase 2 study of neoadjuvant radiation therapy plus concurrent capecitabine and irinotecan or capecitabine and oxaliplatin for patients with locally advanced rectal cancer. (Wong SJ, Moughan J, Meropol NJ, Anne PR, Kachnic LA, Rashid A, Watson JC, Mitchell EP, Pollock J, Lee RJ, Haddock M, Erickson BA, Willett CG) Int J Radiat Oncol Biol Phys 2015 Jan 01;91(1):116-23 31 Citations |
1 | Perfusion computed tomography as functional biomarker in randomized run-in study of bevacizumab and everolimus in well-differentiated neuroendocrine tumors. (Yao JC, Phan AT, Hess K, Fogelman D, Jacobs C, Dagohoy C, Leary C, Xie K, Ng CS) Pancreas 2015 Mar;44(2):190-7 55 Citations |
1 | Weekly versus monthly testosterone administration on fast and slow skeletal muscle fibers in older adult males. (Fitts RH, Peters JR, Dillon EL, Durham WJ, Sheffield-Moore M, Urban RJ) J Clin Endocrinol Metab 2015 Feb;100(2):E223-31 22 Citations |
1 | A phase 1 study of vorinostat maintenance after autologous transplant in high-risk lymphoma. (Hofmeister CC, Williams N, Geyer S, Hade EM, Bowers MA, Earl CT, Vaughn J, Bingman A, Humphries K, Lozanski G, Baiocchi RA, Jaglowski SM, Blum K, Porcu P, Flynn J, Penza S, Benson DM, Andritsos LA, Devine SM) Leuk Lymphoma 2015 Apr;56(4):1043-9 7 Citations |
1 | Association of duration of neuroprotective magnesium sulfate infusion with neonatal and maternal outcomes. (McPherson JA, Rouse DJ, Grobman WA, Palatnik A, Stamilio DM) Obstet Gynecol 2014 Oct;124(4):749-755 27 Citations |
1 | A phase I study of imatinib, dacarbazine, and capecitabine in advanced endocrine cancers. (Halperin DM, Phan AT, Hoff AO, Aaron M, Yao JC, Hoff PM) BMC Cancer 2014 Aug 02;14:561 12 Citations |
1 | Bortezomib for refractory autoimmunity in pediatrics. (Khandelwal P, Davies SM, Grimley MS, Jordan MB, Curtis BR, Jodele S, Marsh R, Filipovich AH) Biol Blood Marrow Transplant 2014 Oct;20(10):1654-9 42 Citations |
1 | Dose selection, pharmacokinetics, and pharmacodynamics of BRAF inhibitor dabrafenib (GSK2118436). (Falchook GS, Long GV, Kurzrock R, Kim KB, Arkenau HT, Brown MP, Hamid O, Infante JR, Millward M, Pavlick A, Chin MT, O'Day SJ, Blackman SC, Curtis CM, Lebowitz P, Ma B, Ouellet D, Kefford RF) Clin Cancer Res 2014 Sep 01;20(17):4449-58 54 Citations |
1 | Phase 1, open-label, dose-escalation, and pharmacokinetic study of STAT3 inhibitor OPB-31121 in subjects with advanced solid tumors. (Bendell JC, Hong DS, Burris HA 3rd, Naing A, Jones SF, Falchook G, Bricmont P, Elekes A, Rock EP, Kurzrock R) Cancer Chemother Pharmacol 2014 Jul;74(1):125-30 89 Citations |
1 | Dual inhibition of the vascular endothelial growth factor pathway: a phase 1 trial evaluating bevacizumab and AZD2171 (cediranib) in patients with advanced solid tumors. (Hong DS, Garrido-Laguna I, Ekmekcioglu S, Falchook GS, Naing A, Wheler JJ, Fu S, Moulder SL, Piha-Paul S, Tsimberidou AM, Wen Y, Culotta KS, Anderes K, Davis DW, Liu W, George GC, Camacho LH, Percy Ivy S, Kurzrock R) Cancer 2014 Jul 15;120(14):2164-73 29 Citations |
1 | Transferring from clopidogrel loading dose to prasugrel loading dose in acute coronary syndrome patients. High on-treatment platelet reactivity analysis of the TRIPLET trial. (Diodati JG, Saucedo JF, Cardillo TE, Jakubowski JA, Henneges C, Effron MB, Lipkin FR, Walker JR, Duvvuru S, Sundseth SS, Fisher HN, Angiolillo DJ) Thromb Haemost 2014 Aug;112(2):311-22 8 Citations |
1 | Malignant Otitis Externa: Evolving Pathogens and Implications for Diagnosis and Treatment. (Hobson CE, Moy JD, Byers KE, Raz Y, Hirsch BE, McCall AA) Otolaryngol Head Neck Surg 2014 Jul;151(1):112-6 60 Citations |
1 | Imatinib-induced postoperative periorbital purpura: GASP (Gleevec-Associated Surgical Purpura) in a woman with imatinib-treated chronic myelogenous leukemia. (Anzalone CL, Cohen PR, Kurzrock R, Cortes JE) Dermatol Online J 2014 Jan 15;20(1):21242 6 Citations |
1 | Atypical lentigines in a man with mixed African American and white race/ethnicity receiving long-term voriconazole therapy. (Massey PR, Wanat KA, Elenitsas R, Rosenbach M) JAMA Dermatol 2014 Mar;150(3):334-5 4 Citations |
1 | Nodular regenerative hyperplasia (NRH) complicating oxaliplatin chemotherapy in patients undergoing resection of colorectal liver metastases. (Morris-Stiff G, White AD, Gomez D, Cameron IC, Farid S, Toogood GJ, Lodge JP, Prasad KR) Eur J Surg Oncol 2014 Aug;40(8):1016-20 28 Citations |
1 | Double-blind, randomized, phase 2 trial of maintenance sunitinib versus placebo after response to chemotherapy in patients with advanced urothelial carcinoma. (Grivas PD, Daignault S, Tagawa ST, Nanus DM, Stadler WM, Dreicer R, Kohli M, Petrylak DP, Vaughn DJ, Bylow KA, Wong SG, Sottnik JL, Keller ET, Al-Hawary M, Smith DC, Hussain M) Cancer 2014 Mar 01;120(5):692-701 92 Citations |
1 | Effect of clopidogrel use post coronary artery bypass surgery on graft patency. (Ebrahimi R, Bakaeen FG, Uberoi A, Ardehali A, Baltz JH, Hattler B, Almassi GH, Wagner TH, Collins JF, Grover FL, Shroyer AL) Ann Thorac Surg 2014 Jan;97(1):15-21 40 Citations |
1 | Dual HER2 inhibition in combination with anti-VEGF treatment is active in heavily pretreated HER2-positive breast cancer. (Falchook GS, Moulder SL, Wheler JJ, Jiang Y, Bastida CC, Kurzrock R) Ann Oncol 2013 Dec;24(12):3004-11 25 Citations |
2 | CaMKII activity in the ventral tegmental area gates cocaine-induced synaptic plasticity in the nucleus accumbens. (Liu X, Liu Y, Zhong P, Wilkinson B, Qi J, Olsen CM, Bayer KU, Liu QS) Neuropsychopharmacology 2014 Mar;39(4):989-99 30 Citations |
1 | Weekly nab-Rapamycin in patients with advanced nonhematologic malignancies: final results of a phase I trial. (Gonzalez-Angulo AM, Meric-Bernstam F, Chawla S, Falchook G, Hong D, Akcakanat A, Chen H, Naing A, Fu S, Wheler J, Moulder S, Helgason T, Li S, Elias I, Desai N, Kurzrock R) Clin Cancer Res 2013 Oct 01;19(19):5474-84 69 Citations |
1 | ED administration of thienopyridines in non-ST-segment elevation myocardial infarction: results from the NCDR. (Diercks DB, Kontos MC, Hollander JE, Mumma BE, Holmes DN, Wiviott S, Saucedo JF, de Lemos JA) Am J Emerg Med 2013 Jul;31(7):1005-11 1 Citation |
1 | Treatment of Epstein Barr virus-induced haemophagocytic lymphohistiocytosis with rituximab-containing chemo-immunotherapeutic regimens. (Chellapandian D, Das R, Zelley K, Wiener SJ, Zhao H, Teachey DT, Nichols KE, EBV-HLH Rituximab Study Group) Br J Haematol 2013 Aug;162(3):376-82 170 Citations |
1 | Multicenter phase II trial of topotecan, cisplatin and bevacizumab for recurrent or persistent cervical cancer. (Zighelboim I, Wright JD, Gao F, Case AS, Massad LS, Mutch DG, Powell MA, Thaker PH, Eisenhauer EL, Cohn DE, Valea FA, Alvarez Secord A, Lippmann LT, Dehdashti F, Rader JS) Gynecol Oncol 2013 Jul;130(1):64-8 66 Citations |
1 | A phase I dose-finding, safety and tolerability study of AZD8330 in patients with advanced malignancies. (Cohen RB, Aamdal S, Nyakas M, Cavallin M, Green D, Learoyd M, Smith I, Kurzrock R) Eur J Cancer 2013 May;49(7):1521-9 36 Citations |
1 | Enteral intestinal alkaline phosphatase administration in newborns decreases iNOS expression in a neonatal necrotizing enterocolitis rat model. (Rentea RM, Liedel JL, Fredrich K, Pritchard K Jr, Oldham KT, Simpson PM, Gourlay DM) J Pediatr Surg 2013 Jan;48(1):124-8 19 Citations |
2 | Propranolol treatment of infantile hemangiomas: anticipatory guidance for parents and caretakers. (Martin K, Blei F, Chamlin SL, Chiu YE, Frieden IJ, Frommelt PC, Garzon MC, Kwon EK, MacLellan-Tobert S, Mancini AJ, Seefeldt M, Sidbury R, Siegel DH, Drolet BA, Boucek RJ) Pediatr Dermatol 2013;30(1):155-9 31 Citations |
1 | Conversion from twice-daily tacrolimus to once-daily extended release tacrolimus (LCPT): the phase III randomized MELT trial. (Bunnapradist S, Ciechanowski K, West-Thielke P, Mulgaonkar S, Rostaing L, Vasudev B, Budde K, MELT investigators) Am J Transplant 2013 Mar;13(3):760-9 77 Citations |
1 | Automating the medication regimen complexity index. (McDonald MV, Peng TR, Sridharan S, Foust JB, Kogan P, Pezzin LE, Feldman PH) J Am Med Inform Assoc 2013 May 01;20(3):499-505 59 Citations |
1 | Rituximab maintenance versus retreatment in follicular lymphoma. (Palla AR, Hamadani M) Hematol Oncol 2013 Dec;31(4):171-8 5 Citations |
1 | Propranolol use in PHACE syndrome with cervical and intracranial arterial anomalies: collective experience in 32 infants. (Metry D, Frieden IJ, Hess C, Siegel D, Maheshwari M, Baselga E, Chamlin S, Garzon M, Mancini AJ, Powell J, Drolet BA) Pediatr Dermatol 2013;30(1):71-89 78 Citations |
1 | Safety, tolerability, pharmacokinetics and pharmacodynamics of AZD8055 in advanced solid tumours and lymphoma. (Naing A, Aghajanian C, Raymond E, Olmos D, Schwartz G, Oelmann E, Grinsted L, Burke W, Taylor R, Kaye S, Kurzrock R, Banerji U) Br J Cancer 2012 Sep 25;107(7):1093-9 107 Citations |
1 | Activity of the oral MEK inhibitor trametinib in patients with advanced melanoma: a phase 1 dose-escalation trial. (Falchook GS, Lewis KD, Infante JR, Gordon MS, Vogelzang NJ, DeMarini DJ, Sun P, Moy C, Szabo SA, Roadcap LT, Peddareddigari VG, Lebowitz PF, Le NT, Burris HA 3rd, Messersmith WA, O'Dwyer PJ, Kim KB, Flaherty K, Bendell JC, Gonzalez R, Kurzrock R, Fecher LA) Lancet Oncol 2012 Aug;13(8):782-9 448 Citations |
1 | Safety, pharmacokinetic, pharmacodynamic, and efficacy data for the oral MEK inhibitor trametinib: a phase 1 dose-escalation trial. (Infante JR, Fecher LA, Falchook GS, Nallapareddy S, Gordon MS, Becerra C, DeMarini DJ, Cox DS, Xu Y, Morris SR, Peddareddigari VG, Le NT, Hart L, Bendell JC, Eckhardt G, Kurzrock R, Flaherty K, Burris HA 3rd, Messersmith WA) Lancet Oncol 2012 Aug;13(8):773-81 453 Citations |
1 | A multicenter phase I trial of PX-866, an oral irreversible phosphatidylinositol 3-kinase inhibitor, in patients with advanced solid tumors. (Hong DS, Bowles DW, Falchook GS, Messersmith WA, George GC, O'Bryant CL, Vo AC, Klucher K, Herbst RS, Eckhardt SG, Peterson S, Hausman DF, Kurzrock R, Jimeno A) Clin Cancer Res 2012 Aug 01;18(15):4173-82 154 Citations |
1 | A phase I first-in-human trial of bardoxolone methyl in patients with advanced solid tumors and lymphomas. (Hong DS, Kurzrock R, Supko JG, He X, Naing A, Wheler J, Lawrence D, Eder JP, Meyer CJ, Ferguson DA, Mier J, Konopleva M, Konoplev S, Andreeff M, Kufe D, Lazarus H, Shapiro GI, Dezube BJ) Clin Cancer Res 2012 Jun 15;18(12):3396-406 188 Citations |
1 | Pharmacokinetic and pharmacodynamic effects of elinogrel: results of the platelet function substudy from the intravenous and oral administration of elinogrel to evaluate tolerability and efficacy in nonurgent percutaneous coronary intervention patients (INNOVATE-PCI) trial. (Angiolillo DJ, Welsh RC, Trenk D, Neumann FJ, Conley PB, McClure MW, Stephens G, Kochman J, Jennings LK, Gurbel PA, Wójcik J, Dabrowski M, Saucedo JF, Stumpf J, Buerke M, Broderick S, Harrington RA, Rao SV) Circ Cardiovasc Interv 2012 Jun;5(3):347-56 30 Citations |
1 | Dabrafenib in patients with melanoma, untreated brain metastases, and other solid tumours: a phase 1 dose-escalation trial. (Falchook GS, Long GV, Kurzrock R, Kim KB, Arkenau TH, Brown MP, Hamid O, Infante JR, Millward M, Pavlick AC, O'Day SJ, Blackman SC, Curtis CM, Lebowitz P, Ma B, Ouellet D, Kefford RF) Lancet 2012 May 19;379(9829):1893-901 797 Citations |
1 | Clofarabine plus cytarabine compared with cytarabine alone in older patients with relapsed or refractory acute myelogenous leukemia: results from the CLASSIC I Trial. (Faderl S, Wetzler M, Rizzieri D, Schiller G, Jagasia M, Stuart R, Ganguly S, Avigan D, Craig M, Collins R, Maris M, Kovacsovics T, Goldberg S, Seiter K, Hari P, Greiner J, Vey N, Recher C, Ravandi F, Wang ES, Vasconcelles M, Huebner D, Kantarjian HM) J Clin Oncol 2012 Jul 10;30(20):2492-9 154 Citations |
2 | Fludarabine-based conditioning for marrow transplantation from unrelated donors in severe aplastic anemia: early results of a cyclophosphamide dose deescalation study show life-threatening adverse events at predefined cyclophosphamide dose levels. (Tolar J, Deeg HJ, Arai S, Horwitz M, Antin JH, McCarty JM, Adams RH, Ewell M, Leifer ES, Gersten ID, Carter SL, Horowitz MM, Nakamura R, Pulsipher MA, Difronzo NL, Confer DL, Eapen M, Anderlini P) Biol Blood Marrow Transplant 2012 Jul;18(7):1007-11 42 Citations |
1 | Phase I study of RO4929097, a gamma secretase inhibitor of Notch signaling, in patients with refractory metastatic or locally advanced solid tumors. (Tolcher AW, Messersmith WA, Mikulski SM, Papadopoulos KP, Kwak EL, Gibbon DG, Patnaik A, Falchook GS, Dasari A, Shapiro GI, Boylan JF, Xu ZX, Wang K, Koehler A, Song J, Middleton SA, Deutsch J, Demario M, Kurzrock R, Wheler JJ) J Clin Oncol 2012 Jul 01;30(19):2348-53 211 Citations |
2 | What is the optimal follicular size before triggering ovulation in intrauterine insemination cycles with clomiphene citrate or letrozole? An analysis of 988 cycles. (Palatnik A, Strawn E, Szabo A, Robb P) Fertil Steril 2012 May;97(5):1089-94.e1-3 32 Citations |
1 | Controlled pauses at the initiation of sodium nitroprusside-enhanced cardiopulmonary resuscitation facilitate neurological and cardiac recovery after 15 mins of untreated ventricular fibrillation. (Yannopoulos D, Segal N, McKnite S, Aufderheide TP, Lurie KG) Crit Care Med 2012 May;40(5):1562-9 13 Citations |
1 | Long-term efficacy of ustekinumab in patients with moderate-to-severe psoriasis: results from the PHOENIX 1 trial through up to 3 years. (Kimball AB, Gordon KB, Fakharzadeh S, Yeilding N, Szapary PO, Schenkel B, Guzzo C, Li S, Papp KA) Br J Dermatol 2012 Apr;166(4):861-72 122 Citations |
1 | Myeloablative transplantation using either cord blood or bone marrow leads to immune recovery, high long-term donor chimerism and excellent survival in chronic granulomatous disease. (Tewari P, Martin PL, Mendizabal A, Parikh SH, Page KM, Driscoll TA, Malech HL, Kurtzberg J, Prasad VK) Biol Blood Marrow Transplant 2012 Sep;18(9):1368-77 37 Citations |
1 | Ten-year outcome after rapid discontinuation of prednisone in adult primary kidney transplantation. (Rizzari MD, Suszynski TM, Gillingham KJ, Dunn TB, Ibrahim HN, Payne WD, Chinnakotla S, Finger EB, Sutherland DE, Kandaswamy R, Najarian JS, Pruett TL, Kukla A, Spong R, Matas AJ) Clin J Am Soc Nephrol 2012 Mar;7(3):494-503 61 Citations |
1 | Intermediate-dose versus low-dose cyclophosphamide and granulocyte colony-stimulating factor for peripheral blood stem cell mobilization in patients with multiple myeloma treated with novel induction therapies. (Hamadani M, Kochuparambil ST, Osman S, Cumpston A, Leadmon S, Bunner P, Watkins K, Morrison D, Speir E, Deremer D, Kota V, Jillella A, Craig M, Awan F) Biol Blood Marrow Transplant 2012 Jul;18(7):1128-35 59 Citations |
1 | Safety, pharmacokinetics, and activity of GRN1005, a novel conjugate of angiopep-2, a peptide facilitating brain penetration, and paclitaxel, in patients with advanced solid tumors. (Kurzrock R, Gabrail N, Chandhasin C, Moulder S, Smith C, Brenner A, Sankhala K, Mita A, Elian K, Bouchard D, Sarantopoulos J) Mol Cancer Ther 2012 Feb;11(2):308-16 139 Citations |
1 | The setpoint study (ACTG A5217): effect of immediate versus deferred antiretroviral therapy on virologic set point in recently HIV-1-infected individuals. (Hogan CM, Degruttola V, Sun X, Fiscus SA, Del Rio C, Hare CB, Markowitz M, Connick E, Macatangay B, Tashima KT, Kallungal B, Camp R, Morton T, Daar ES, Little S, A5217 Study Team) J Infect Dis 2012 Jan 01;205(1):87-96 94 Citations |
1 | Psychosis in the context of sodium oxybate therapy. (Langford J, Gross WL) J Clin Sleep Med 2011 Dec 15;7(6):665-6 14 Citations |
1 | Long-term safety experience of ustekinumab in patients with moderate to severe psoriasis (Part II of II): results from analyses of infections and malignancy from pooled phase II and III clinical trials. (Gordon KB, Papp KA, Langley RG, Ho V, Kimball AB, Guzzo C, Yeilding N, Szapary PO, Fakharzadeh S, Li S, Hsu MC, Reich K) J Am Acad Dermatol 2012 May;66(5):742-51 120 Citations |
1 | Sequential vs. concurrent chemoradiation for stage III non-small cell lung cancer: randomized phase III trial RTOG 9410. (Curran WJ Jr, Paulus R, Langer CJ, Komaki R, Lee JS, Hauser S, Movsas B, Wasserman T, Rosenthal SA, Gore E, Machtay M, Sause W, Cox JD) J Natl Cancer Inst 2011 Oct 05;103(19):1452-60 1001 Citations |
1 | A phase I trial of liposomal doxorubicin, bevacizumab, and temsirolimus in patients with advanced gynecologic and breast malignancies. (Moroney JW, Schlumbrecht MP, Helgason T, Coleman RL, Moulder S, Naing A, Bodurka DC, Janku F, Hong DS, Kurzrock R) Clin Cancer Res 2011 Nov 01;17(21):6840-6 45 Citations |
1 | Dietary selenium for the mitigation of radiation injury: effects of selenium dose escalation and timing of supplementation. (Sieber F, Muir SA, Cohen EP, Fish BL, Mäder M, Schock AM, Althouse BJ, Moulder JE) Radiat Res 2011 Sep;176(3):366-74 31 Citations |
1 | A phase 1 dose escalation, pharmacokinetic, and pharmacodynamic evaluation of eIF-4E antisense oligonucleotide LY2275796 in patients with advanced cancer. (Hong DS, Kurzrock R, Oh Y, Wheler J, Naing A, Brail L, Callies S, André V, Kadam SK, Nasir A, Holzer TR, Meric-Bernstam F, Fishman M, Simon G) Clin Cancer Res 2011 Oct 15;17(20):6582-91 108 Citations |
2 | Radiation Therapy Oncology Group 0247: a randomized Phase II study of neoadjuvant capecitabine and irinotecan or capecitabine and oxaliplatin with concurrent radiotherapy for patients with locally advanced rectal cancer. (Wong SJ, Winter K, Meropol NJ, Anne PR, Kachnic L, Rashid A, Watson JC, Mitchell E, Pollock J, Lee RJ, Haddock M, Erickson BA, Willett CG) Int J Radiat Oncol Biol Phys 2012 Mar 15;82(4):1367-75 66 Citations |
3 | Recovery of hippocampal network connectivity correlates with cognitive improvement in mild Alzheimer's disease patients treated with donepezil assessed by resting-state fMRI. (Goveas JS, Xie C, Ward BD, Wu Z, Li W, Franczak M, Jones JL, Antuono PG, Li SJ) J Magn Reson Imaging 2011 Oct;34(4):764-73 82 Citations |
1 | Phase 1b-2a study to reverse platinum resistance through use of a hypomethylating agent, azacitidine, in patients with platinum-resistant or platinum-refractory epithelial ovarian cancer. (Fu S, Hu W, Iyer R, Kavanagh JJ, Coleman RL, Levenback CF, Sood AK, Wolf JK, Gershenson DM, Markman M, Hennessy BT, Kurzrock R, Bast RC Jr) Cancer 2011 Apr 15;117(8):1661-9 146 Citations |
1 | Tuberculin skin test and isoniazid prophylaxis among health care workers in high tuberculosis prevalence areas. (Khawcharoenporn T, Apisarnthanarak A, Sungkanuparph S, Woeltje KF, Fraser VJ) Int J Tuberc Lung Dis 2011 Jan;15(1):14-23 13 Citations |
1 | Phase I clinical trial of MPC-6827 (Azixa), a microtubule destabilizing agent, in patients with advanced cancer. (Tsimberidou AM, Akerley W, Schabel MC, Hong DS, Uehara C, Chhabra A, Warren T, Mather GG, Evans BA, Woodland DP, Swabb EA, Kurzrock R) Mol Cancer Ther 2010 Dec;9(12):3410-9 47 Citations |
1 | Stimulation of the young poor responder: comparison of the luteal estradiol/gonadotropin-releasing hormone antagonist priming protocol versus oral contraceptive microdose leuprolide. (Shastri SM, Barbieri E, Kligman I, Schoyer KD, Davis OK, Rosenwaks Z) Fertil Steril 2011 Feb;95(2):592-5 38 Citations |
1 | Dramatic improvement of inoperable angiosarcoma with combination paclitaxel and bevacizumab chemotherapy. (Fuller CK, Charlson JA, Dankle SK, Russell TJ) J Am Acad Dermatol 2010 Oct;63(4):e83-4 35 Citations |
1 | Response of histiocytoses to imatinib mesylate: fire to ashes. (Janku F, Amin HM, Yang D, Garrido-Laguna I, Trent JC, Kurzrock R) J Clin Oncol 2010 Nov 01;28(31):e633-6 74 Citations |
1 | Preclinical and pilot clinical studies of docetaxel chemoradiation for Stage III non-small-cell lung cancer. (Chen Y, Pandya KJ, Hyrien O, Keng PC, Smudzin T, Anderson J, Qazi R, Smith B, Watson TJ, Feins RH, Johnstone DW) Int J Radiat Oncol Biol Phys 2011 Aug 01;80(5):1358-64 6 Citations |
1 | A phase II study of oxaliplatin, 5-fluorouracil, leucovorin, and high-dose capecitabine in patients with metastatic colorectal cancer. (Lubner SJ, Loconte NK, Holen KD, Schelman W, Thomas JP, Jumonville A, Eickhoff JC, Seo S, Mulkerin DL) Clin Colorectal Cancer 2010 Jul;9(3):157-61 6 Citations |
1 | Efficacy and safety of adalimumab across subgroups of patients with moderate to severe psoriasis. (Menter A, Gordon KB, Leonardi CL, Gu Y, Goldblum OM) J Am Acad Dermatol 2010 Sep;63(3):448-56 137 Citations |
1 | Ustekinumab significantly improves symptoms of anxiety, depression, and skin-related quality of life in patients with moderate-to-severe psoriasis: Results from a randomized, double-blind, placebo-controlled phase III trial. (Langley RG, Feldman SR, Han C, Schenkel B, Szapary P, Hsu MC, Ortonne JP, Gordon KB, Kimball AB) J Am Acad Dermatol 2010 Sep;63(3):457-65 182 Citations |
3 | Efficacy and safety of long-term (>7 year) alemtuzumab therapy for refractory T-cell large granular lymphocytic leukaemia. (Olteanu H, Harrington AM, Ramirez S, Kroft SH, Hari P) Br J Haematol 2010 Aug;150(4):480-1 3 Citations |
1 | Prenatal or postnatal indomethacin exposure and neonatal gut injury associated with isolated intestinal perforation and necrotizing enterocolitis. (Sharma R, Hudak ML, Tepas JJ 3rd, Wludyka PS, Teng RJ, Hastings LK, Renfro WH, Marvin WJ Jr) J Perinatol 2010 Dec;30(12):786-93 51 Citations |
1 | Phase I clinical trial of hepatic arterial infusion of cisplatin in combination with intravenous liposomal doxorubicin in patients with advanced cancer and dominant liver involvement. (Tsimberidou AM, Moulder S, Fu S, Wen S, Naing A, Bedikian AY, Daring S, Uehara C, Ng C, Wallace M, Camacho L, Kurzrock R) Cancer Chemother Pharmacol 2010 Nov;66(6):1087-93 15 Citations |
1 | Trimodality therapy without a platinum compound for localized carcinoma of the esophagus and gastroesophageal junction. (Ajani JA, Correa AM, Walsh GL, Komaki R, Lee JH, Vaporciyan AA, Rice DC, Yao JC, Maru DM, Hofstetter WL, Phan AT, Swisher SG) Cancer 2010 Apr 01;116(7):1656-63 15 Citations |
1 | Chemoradiation in locally advanced cervical carcinoma: an analysis of cisplatin dosing and other clinical prognostic factors. (Nugent EK, Case AS, Hoff JT, Zighelboim I, DeWitt LL, Trinkhaus K, Mutch DG, Thaker PH, Massad LS, Rader JS) Gynecol Oncol 2010 Mar;116(3):438-41 56 Citations |
1 | Chronic myeloid leukemia: an update of concepts and management recommendations of European LeukemiaNet. (Baccarani M, Cortes J, Pane F, Niederwieser D, Saglio G, Apperley J, Cervantes F, Deininger M, Gratwohl A, Guilhot F, Hochhaus A, Horowitz M, Hughes T, Kantarjian H, Larson R, Radich J, Simonsson B, Silver RT, Goldman J, Hehlmann R, European LeukemiaNet) J Clin Oncol 2009 Dec 10;27(35):6041-51 1119 Citations |
3 | Hypersensitivity reactions to aprotinin re-exposure in paediatric surgery. (Siehr S, Stuth E, Tweddell J, Hoffman G, Troshynski T, Jones D, Mitchell M, Ghanayem N) Eur J Cardiothorac Surg 2010 Feb;37(2):307-11 9 Citations |
1 | A phase I dose escalation study of a pharmacobiologically based scheduling of capecitabine and mitomycin C in patients with gastrointestinal malignancies. (Bekaii-Saab T, Hill M, Campbell A, Kosuri K, Thomas J, Villalona-Calero M) Cancer Chemother Pharmacol 2010 Apr;65(5):863-9 |
1 | Ocular and systemic safety evaluation of calcium formate as a dietary supplement. (Altaweel MM, Hanzlik RP, Ver Hoeve JN, Eells J, Zhang B) J Ocul Pharmacol Ther 2009 Jun;25(3):223-30 3 Citations |
1 | Prolonged disease control by nonmyeloablative allogeneic transplantation for metastatic breast cancer. (de Souza JA, Davis ML, Rondon G, Cheng YC, Jones RB, Champlin RE, Ueno NT) Bone Marrow Transplant 2009 Jul;44(2):81-7 9 Citations |
1 | Transient metabolic alkalosis during early reperfusion abolishes helium preconditioning against myocardial infarction: restoration of cardioprotection by cyclosporin A in rabbits. (Pagel PS, Krolikowski JG) Anesth Analg 2009 Apr;108(4):1076-82 31 Citations |
1 | Phase II study of weekly gemcitabine and vinorelbine for children with recurrent or refractory Hodgkin's disease: a children's oncology group report. (Cole PD, Schwartz CL, Drachtman RA, de Alarcon PA, Chen L, Trippett TM) J Clin Oncol 2009 Mar 20;27(9):1456-61 51 Citations |
1 | Adalimumab safety and mortality rates from global clinical trials of six immune-mediated inflammatory diseases. (Burmester GR, Mease P, Dijkmans BA, Gordon K, Lovell D, Panaccione R, Perez J, Pangan AL) Ann Rheum Dis 2009 Dec;68(12):1863-9 180 Citations |
1 | Effects of short-term finasteride on apoptotic factors and androgen receptors in prostate cancer cells. (Bass R, Perry B, Langenstroer P, Thrasher JB, Dennis KL, Tawfik O, Holzbeierlein J) J Urol 2009 Feb;181(2):615-9; discussion 619-20 24 Citations |
1 | Gastrointestinal tract recovery in patients undergoing bowel resection: results of a randomized trial of alvimopan and placebo with a standardized accelerated postoperative care pathway. (Ludwig K, Enker WE, Delaney CP, Wolff BG, Du W, Fort JG, Cherubini M, Cucinotta J, Techner L) Arch Surg 2008 Nov;143(11):1098-105 127 Citations |
1 | Calcium plus vitamin D supplementation and the risk of breast cancer. (Chlebowski RT, Johnson KC, Kooperberg C, Pettinger M, Wactawski-Wende J, Rohan T, Rossouw J, Lane D, O'Sullivan MJ, Yasmeen S, Hiatt RA, Shikany JM, Vitolins M, Khandekar J, Hubbell FA, Women's Health Initiative Investigators) J Natl Cancer Inst 2008 Nov 19;100(22):1581-91 368 Citations |
2 | Preoperative shower revisited: can high topical antiseptic levels be achieved on the skin surface before surgical admission? (Edmiston CE Jr, Krepel CJ, Seabrook GR, Lewis BD, Brown KR, Towne JB) J Am Coll Surg 2008 Aug;207(2):233-9 91 Citations |
1 | Detection of nonnucleoside reverse-transcriptase inhibitor-resistant HIV-1 after discontinuation of virologically suppressive antiretroviral therapy. (Hare CB, Mellors J, Krambrink A, Su Z, Skiest D, Margolis DM, Patel SS, Barnas D, Frenkel L, Coombs RW, Aweeka F, Morse GD, Haas DW, Boltz V, Palmer S, Coffin J, Havlir DV) Clin Infect Dis 2008 Aug 01;47(3):421-4 28 Citations |
1 | Efficacy and safety of ustekinumab, a human interleukin-12/23 monoclonal antibody, in patients with psoriasis: 76-week results from a randomised, double-blind, placebo-controlled trial (PHOENIX 1). (Leonardi CL, Kimball AB, Papp KA, Yeilding N, Guzzo C, Wang Y, Li S, Dooley LT, Gordon KB, PHOENIX 1 study investigators) Lancet 2008 May 17;371(9625):1665-74 1470 Citations |
1 | Safety and efficacy of ABT-874, a fully human interleukin 12/23 monoclonal antibody, in the treatment of moderate to severe chronic plaque psoriasis: results of a randomized, placebo-controlled, phase 2 trial. (Kimball AB, Gordon KB, Langley RG, Menter A, Chartash EK, Valdes J, ABT-874 Psoriasis Study Investigators) Arch Dermatol 2008 Feb;144(2):200-7 214 Citations |
1 | Phase I study of alternate-week administration of tipifarnib in patients with myelodysplastic syndrome. (Kurzrock R, Kantarjian HM, Blascovich MA, Bucher C, Verstovsek S, Wright JJ, Pilat SR, Cortes JE, Estey EH, Giles FJ, Beran M, Sebti SM) Clin Cancer Res 2008 Jan 15;14(2):509-14 19 Citations |
1 | Phase I-II study of oxaliplatin, fludarabine, cytarabine, and rituximab combination therapy in patients with Richter's syndrome or fludarabine-refractory chronic lymphocytic leukemia. (Tsimberidou AM, Wierda WG, Plunkett W, Kurzrock R, O'Brien S, Wen S, Ferrajoli A, Ravandi-Kashani F, Garcia-Manero G, Estrov Z, Kipps TJ, Brown JR, Fiorentino A, Lerner S, Kantarjian HM, Keating MJ) J Clin Oncol 2008 Jan 10;26(2):196-203 137 Citations |
1 | Repeated N-acetylcysteine administration alters plasticity-dependent effects of cocaine. (Madayag A, Lobner D, Kau KS, Mantsch JR, Abdulhameed O, Hearing M, Grier MD, Baker DA) J Neurosci 2007 Dec 19;27(51):13968-76 195 Citations |
1 | Thyroid function test abnormalities in patients with metastatic renal cell carcinoma treated with sorafenib. (Tamaskar I, Bukowski R, Elson P, Ioachimescu AG, Wood L, Dreicer R, Mekhail T, Garcia J, Rini BI) Ann Oncol 2008 Feb;19(2):265-8 127 Citations |
1 | Final report of RTOG 9610, a multi-institutional trial of reirradiation and chemotherapy for unresectable recurrent squamous cell carcinoma of the head and neck. (Spencer SA, Harris J, Wheeler RH, Machtay M, Schultz C, Spanos W, Rotman M, Meredith R, Ang KK) Head Neck 2008 Mar;30(3):281-8 275 Citations |
3 | The role of transient receptor potential vanilloid 1 in mechanical and chemical visceral hyperalgesia following experimental colitis. (Miranda A, Nordstrom E, Mannem A, Smith C, Banerjee B, Sengupta JN) Neuroscience 2007 Sep 21;148(4):1021-32 139 Citations |
1 | Dynamic changes in CD4+ CD25+(high) T cell apoptosis after the diagnosis of type 1 diabetes. (Glisic-Milosavljevic S, Wang T, Koppen M, Kramer J, Ehlenbach S, Waukau J, Jailwala P, Jana S, Alemzadeh R, Ghosh S) Clin Exp Immunol 2007 Oct;150(1):75-82 31 Citations |
2 | Daily cocaine self-administration under long-access conditions augments restraint-induced increases in plasma corticosterone and impairs glucocorticoid receptor-mediated negative feedback in rats. (Mantsch JR, Cullinan WE, Tang LC, Baker DA, Katz ES, Hoks MA, Ziegler DR) Brain Res 2007 Sep 05;1167:101-11 49 Citations |
1 | A multi-institutional evaluation of factors predictive of toxicity and efficacy of bevacizumab for recurrent ovarian cancer. (Wright JD, Secord AA, Numnum TM, Rocconi RP, Powell MA, Berchuck A, Alvarez RD, Gibb RK, Trinkaus K, Rader JS, Mutch DG) Int J Gynecol Cancer 2008;18(3):400-6 36 Citations |
1 | Statin and statin-fibrate use was significantly associated with increased myositis risk in a managed care population. (McClure DL, Valuck RJ, Glanz M, Murphy JR, Hokanson JE) J Clin Epidemiol 2007 Aug;60(8):812-8 59 Citations |
1 | Neurodevelopmental outcomes of premature infants with severe respiratory failure enrolled in a randomized controlled trial of inhaled nitric oxide. (Hintz SR, Van Meurs KP, Perritt R, Poole WK, Das A, Stevenson DK, Ehrenkranz RA, Lemons JA, Vohr BR, Heyne R, Childers DO, Peralta-Carcelen M, Dusick A, Johnson YR, Morris B, Dillard R, Vaucher Y, Steichen J, Adams-Chapman I, Konduri G, Myers GJ, de Ungria M, Tyson JE, Higgins RD, NICHD Neonatal Research Network) J Pediatr 2007 Jul;151(1):16-22, 22.e1-3 57 Citations |
1 | Long-term safety and efficacy of 50 mg of etanercept twice weekly in patients with psoriasis. (Tyring S, Gordon KB, Poulin Y, Langley RG, Gottlieb AB, Dunn M, Jahreis A) Arch Dermatol 2007 Jun;143(6):719-26 312 Citations |
1 | Complete pathological response to bevacizumab and chemoradiation in advanced rectal cancer. (Willett CG, Duda DG, di Tomaso E, Boucher Y, Czito BG, Vujaskovic Z, Vlahovic G, Bendell J, Cohen KS, Hurwitz HI, Bentley R, Lauwers GY, Poleski M, Wong TZ, Paulson E, Ludwig KA, Jain RK) Nat Clin Pract Oncol 2007 May;4(5):316-21 50 Citations |
1 | Tandem high-dose chemotherapy with autologous peripheral hematopoietic progenitor cell rescue as consolidation therapy for patients with high-risk Ewing family tumors. (Burke MJ, Walterhouse DO, Jacobsohn DA, Duerst RE, Kletzel M) Pediatr Blood Cancer 2007 Aug;49(2):196-8 26 Citations |
1 | Twice vs three times daily heparin dosing for thromboembolism prophylaxis in the general medical population: A metaanalysis. (King CS, Holley AB, Jackson JL, Shorr AF, Moores LK) Chest 2007 Feb;131(2):507-16 103 Citations |
1 | Clinical inquiries. Do topical antibiotics improve wound healing? (Diehr S, Hamp A, Jamieson B, Mendoza M) J Fam Pract 2007 Feb;56(2):140-4 29 Citations |
2 | Rituximab for the treatment of patients with very high-titre acquired factor VIII inhibitors refractory to conventional chemotherapy. (Field JJ, Fenske TS, Blinder MA) Haemophilia 2007 Jan;13(1):46-50 35 Citations |
1 | A randomized, open-label trial of continuous versus interrupted etanercept therapy in the treatment of psoriasis. (Moore A, Gordon KB, Kang S, Gottlieb A, Freundlich B, Xia HA, Stevens SR) J Am Acad Dermatol 2007 Apr;56(4):598-603 149 Citations |
1 | Concurrent capecitabine and upper abdominal radiation therapy is well tolerated. (Das P, Wolff RA, Abbruzzese JL, Varadhachary GR, Evans DB, Vauthey JN, Baschnagel A, Delclos ME, Krishnan S, Janjan NA, Crane CH) Radiat Oncol 2006 Oct 24;1:41 20 Citations |
1 | A randomized trial of treatment interruption before optimized antiretroviral therapy for persons with drug-resistant HIV: 48-week virologic results of ACTG A5086. (Benson CA, Vaida F, Havlir DV, Downey GF, Lederman MM, Gulick RM, Glesby MJ, Wantman M, Bixby CJ, Rinehart AR, Snyder S, Wang R, Patel S, Mellors JW, ACTG A5086 Study Team) J Infect Dis 2006 Nov 01;194(9):1309-18 19 Citations |
1 | Effects of continuous and intermittent estrogen treatments on memory in aging female mice. (Gresack JE, Frick KM) Brain Res 2006 Oct 18;1115(1):135-47 52 Citations |
1 | The Valsartan Antihypertensive Long-Term Use Evaluation (VALUE) trial: outcomes in patients receiving monotherapy. (Julius S, Weber MA, Kjeldsen SE, McInnes GT, Zanchetti A, Brunner HR, Laragh J, Schork MA, Hua TA, Amerena J, Balazovjech I, Cassel G, Herczeg B, Koylan N, Magometschnigg D, Majahalme S, Martinez F, Oigman W, Seabra Gomes R, Zhu JR) Hypertension 2006 Sep;48(3):385-91 129 Citations |
1 | Phase II evaluation of a 3-day infusion of topotecan in patients with recurrent ovarian or primary peritoneal cancer. (Herzog TJ, Powell MA, Rader JS, Gibb R, Mutch DG) Gynecol Oncol 2006 Nov;103(2):637-41 11 Citations |
1 | Maintenance rituximab following induction chemoimmunotherapy may prolong progression-free survival in mantle cell lymphoma: a pilot study from the Wisconsin Oncology Network. (Kahl BS, Longo WL, Eickhoff JC, Zehnder J, Jones C, Blank J, McFarland T, Bottner W, Rezazedeh H, Werndli J, Bailey HH, Wisconsin Oncology Network) Ann Oncol 2006 Sep;17(9):1418-23 97 Citations |
1 | Involvement of the endocannabinoid system in the ability of long-term tricyclic antidepressant treatment to suppress stress-induced activation of the hypothalamic-pituitary-adrenal axis. (Hill MN, Ho WS, Sinopoli KJ, Viau V, Hillard CJ, Gorzalka BB) Neuropsychopharmacology 2006 Dec;31(12):2591-9 108 Citations |
1 | Parachutes and prophylaxis: they both work! (White GC 2nd) J Thromb Haemost 2006 Jun;4(6):1226-7 7 Citations |
1 | Phase I trial evaluating the safety of bevacizumab with concurrent radiotherapy and capecitabine in locally advanced pancreatic cancer. (Crane CH, Ellis LM, Abbruzzese JL, Amos C, Xiong HQ, Ho L, Evans DB, Tamm EP, Ng C, Pisters PW, Charnsangavej C, Delclos ME, O'Reilly M, Lee JE, Wolff RA) J Clin Oncol 2006 Mar 01;24(7):1145-51 197 Citations |
1 | Efficacy of etanercept in an integrated multistudy database of patients with psoriasis. (Gordon K, Korman N, Frankel E, Wang H, Jahreis A, Zitnik R, Chang T) J Am Acad Dermatol 2006 Mar;54(3 Suppl 2):S101-11 88 Citations |
1 | Multicenter phase II trial of S-1 plus cisplatin in patients with untreated advanced gastric or gastroesophageal junction adenocarcinoma. (Ajani JA, Lee FC, Singh DA, Haller DG, Lenz HJ, Benson AB 3rd, Yanagihara R, Phan AT, Yao JC, Strumberg D) J Clin Oncol 2006 Feb 01;24(4):663-7 92 Citations |
1 | Effects of post-training hippocampal injections of midazolam on fear conditioning. (Gafford GM, Parsons RG, Helmstetter FJ) Learn Mem 2005;12(6):573-8 20 Citations |
1 | Refractory Hodgkin lymphoma responds to pentostatin (2'-deoxycoformycin). (Braiteh F, Ng C, Kurzrock R) Leuk Lymphoma 2006 Feb;47(2):373-5 5 Citations |
1 | Phase-dependent treatment of delayed sleep phase syndrome with melatonin. (Mundey K, Benloucif S, Harsanyi K, Dubocovich ML, Zee PC) Sleep 2005 Oct;28(10):1271-8 191 Citations |
1 | A phase II trial of gemcitabine, 5-fluorouracil and leucovorin in advanced esophageal carcinoma. (Morgan-Meadows S, Mulkerin D, Berlin JD, Kim K, Bailey H, Saphner T, Jumonville A, Hansen R, Ahuja H, McFarland T, Thomas JP) Oncology 2005;69(2):130-4 15 Citations |
1 | The impact of oral phenylpropanolamine on blood pressure: a meta-analysis and review of the literature. (Salerno SM, Jackson JL, Berbano EP) J Hum Hypertens 2005 Aug;19(8):643-52 28 Citations |
1 | A phase I and pharmacologic trial of two schedules of the proteasome inhibitor, PS-341 (bortezomib, velcade), in patients with advanced cancer. (Dy GK, Thomas JP, Wilding G, Bruzek L, Mandrekar S, Erlichman C, Alberti D, Binger K, Pitot HC, Alberts SR, Hanson LJ, Marnocha R, Tutsch K, Kaufmann SH, Adjei AA) Clin Cancer Res 2005 May 01;11(9):3410-6 66 Citations |
1 | Phase I study of BMS-214662, a farnesyl transferase inhibitor in patients with acute leukemias and high-risk myelodysplastic syndromes. (Cortes J, Faderl S, Estey E, Kurzrock R, Thomas D, Beran M, Garcia-Manero G, Ferrajoli A, Giles F, Koller C, O'Brien S, Wright J, Bai SA, Kantarjian H) J Clin Oncol 2005 Apr 20;23(12):2805-12 49 Citations |
1 | Efficacy and safety observed during 24 weeks of efalizumab therapy in patients with moderate to severe plaque psoriasis. (Menter A, Gordon K, Carey W, Hamilton T, Glazer S, Caro I, Li N, Gulliver W) Arch Dermatol 2005 Jan;141(1):31-8 215 Citations |
1 | Extended efalizumab therapy sustains efficacy without increasing toxicity in patients with moderate to severe chronic plaque psoriasis. (Gottlieb AB, Gordon KB, Lebwohl MG, Caro I, Walicke PA, Li N, Leonardi CL, EFALIZUMAB STUDY GROUP) J Drugs Dermatol 2004;3(6):614-24 80 Citations |
1 | Fluorouracil, doxorubicin, and streptozocin in the treatment of patients with locally advanced and metastatic pancreatic endocrine carcinomas. (Kouvaraki MA, Ajani JA, Hoff P, Wolff R, Evans DB, Lozano R, Yao JC) J Clin Oncol 2004 Dec 01;22(23):4762-71 509 Citations |
1 | Perceived versus actual medication regimens among internal medicine patients. (McKinley BT, Mulhall BP, Jackson JL) Mil Med 2004 Jun;169(6):451-4 10 Citations |
1 | Pilot study of etanercept in patients with relapsed cutaneous T-cell lymphomas. (Tsimberidou AM, Giles FJ, Duvic M, Kurzrock R) J Am Acad Dermatol 2004 Aug;51(2):200-4 27 Citations |
1 | Comparison of preoperative carprofen and postoperative butorphanol as postsurgical analgesics in cats undergoing ovariohysterectomy. (Al-Gizawiy MM, P Rudé E) Vet Anaesth Analg 2004 Jul;31(3):164-74 54 Citations |
1 | Cardiac safety profile of prolonged (>or=6 cycles) pegylated liposomal doxorubicin administration in patients with gynecologic malignancies. (Uyar D, Kulp B, Peterson G, Zanotti K, Markman M, Belinson J) Gynecol Oncol 2004 Jul;94(1):147-51 41 Citations |
1 | Phase II study of gemcitabine in combination with docetaxel in patients with advanced pancreatic carcinoma (E1298). A trial of the eastern cooperative oncology group. (Shepard RC, Levy DE, Berlin JD, Stuart K, Harris JE, Aviles V, Thomas JP, Benson AB 3rd) Oncology 2004;66(4):303-9 34 Citations |
2 | Chronic administration of nitric oxide reduces angiotensin II receptor type 1 expression and aldosterone synthesis in zona glomerulosa cells. (Nithipatikom K, Holmes BB, McCoy MJ, Hillard CJ, Campbell WB) Am J Physiol Endocrinol Metab 2004 Nov;287(5):E820-7 11 Citations |
2 | Cardioprotection by glucose-insulin-potassium: dependence on KATP channel opening and blood glucose concentration before ischemia. (LaDisa JF Jr, Krolikowski JG, Pagel PS, Warltier DC, Kersten JR) Am J Physiol Heart Circ Physiol 2004 Aug;287(2):H601-7 35 Citations |
1 | Host conditioning is a primary determinant in modulating the effect of IL-7 on murine graft-versus-host disease. (Gendelman M, Hecht T, Logan B, Vodanovic-Jankovic S, Komorowski R, Drobyski WR) J Immunol 2004 Mar 01;172(5):3328-36 31 Citations |
1 | Activity of interferon-alpha and isotretinoin in patients with advanced, refractory lymphoid malignancies. (Tsimberidou AM, Giles F, Romaguera J, Duvic M, Kurzrock R) Cancer 2004 Feb 01;100(3):574-80 21 Citations |
1 | Patient-controlled analgesia for sickle cell pain crisis in a pediatric emergency department. (Melzer-Lange MD, Walsh-Kelly CM, Lea G, Hillery CA, Scott JP) Pediatr Emerg Care 2004 Jan;20(1):2-4 45 Citations |
1 | Phase II study of pentostatin in advanced T-cell lymphoid malignancies: update of an M.D. Anderson Cancer Center series. (Tsimberidou AM, Giles F, Duvic M, Fayad L, Kurzrock R) Cancer 2004 Jan 15;100(2):342-9 70 Citations |
1 | Reduced hypoglycemic episodes and improved glycemic control in children with type 1 diabetes using insulin glargine and neutral protamine Hagedorn insulin. (Chase HP, Dixon B, Pearson J, Fiallo-Scharer R, Walravens P, Klingensmith G, Rewers M, Garg SK) J Pediatr 2003 Dec;143(6):737-40 110 Citations |
1 | Sequential interleukin 3 and granulocyte-macrophage-colony stimulating factor therapy in patients with bone marrow failure with long-term follow-up of responses. (Wu HH, Talpaz M, Champlin RE, Pilat SR, Kurzrock R) Cancer 2003 Dec 01;98(11):2410-9 20 Citations |
1 | A randomized phase II evaluation of bryostatin-1 (NSC #339555) in persistent or recurrent squamous cell carcinoma of the cervix: A Gynecologic Oncology Group Study. (Armstrong DK, Blessing JA, Rader J, Sorosky JI, Gynecologic Oncology Group Study) Invest New Drugs 2003 Nov;21(4):453-7 18 Citations |
1 | Late-gestation betamethasone enhances coronary artery responsiveness to angiotensin II in fetal sheep. (Roghair RD, Lamb FS, Bedell KA, Smith OM, Scholz TD, Segar JL) Am J Physiol Regul Integr Comp Physiol 2004 Jan;286(1):R80-8 22 Citations |
1 | Combination treatment of PKD utilizing dual inhibition of EGF-receptor activity and ligand bioavailability. (Sweeney WE Jr, Hamahira K, Sweeney J, Garcia-Gatrell M, Frost P, Avner ED) Kidney Int 2003 Oct;64(4):1310-9 65 Citations |
1 | Early short-term treatment with doxycycline modulates postinfarction left ventricular remodeling. (Villarreal FJ, Griffin M, Omens J, Dillmann W, Nguyen J, Covell J) Circulation 2003 Sep 23;108(12):1487-92 126 Citations |
1 | Cholinergic interneurons of the nucleus accumbens and dorsal striatum are activated by the self-administration of cocaine. (Berlanga ML, Olsen CM, Chen V, Ikegami A, Herring BE, Duvauchelle CL, Alcantara AA) Neuroscience 2003;120(4):1149-56 58 Citations |
1 | Clinical inquiries. How effective is desmopressin for primary nocturnal enuresis? (Diehr S, Scoville C, Bercaw DM) J Fam Pract 2003 Jul;52(7):568-9 1 Citation |
2 | Adenosine type 1 (A1) receptors mediate protection against myocardial infarction produced by chronic, intermittent ingestion of ethanol in dogs. (Kehl F, Krolikowski JG, LaDisa JF Jr, Kersten JR, Warltier DC, Pagel PS) Int J Cardiol 2003 Apr;88(2-3):175-82 6 Citations |
1 | Elimination of leukemia in the absence of lethal graft-versus-host disease after allogenic bone marrow transplantation. (Drobyski WR, Gendelman M, Vodanovic-Jankovic S, Gorski J) J Immunol 2003 Mar 15;170(6):3046-53 16 Citations |
1 | A phase II study of concomitant hyperfractionated radiation therapy and double dose intra-arterial cisplatin for squamous cell carcinoma of the head and neck. (Regine WF, Valentino J, Arnold SM, Sloan D, Kenady D, Strottmann J, Mohiuddin M) Technol Cancer Res Treat 2002 Apr;1(2):133-40 2 Citations |
1 | Tiotropium: an inhaled, long-acting anticholinergic drug for chronic obstructive pulmonary disease. (Panning CA, DeBisschop M) Pharmacotherapy 2003 Feb;23(2):183-9 25 Citations |
1 | Does oral creatine supplementation improve strength? A meta-analysis. (Dempsey RL, Mazzone MF, Meurer LN) J Fam Pract 2002 Nov;51(11):945-51 33 Citations |
1 | Phase I study of rubitecan and gemcitabine in patients with advanced malignancies. (Fracasso PM, Rader JS, Govindan R, Herzog TJ, Arquette MA, Denes A, Mutch DG, Picus J, Tan BR, Fears CL, Goodner SA, Sun SL) Ann Oncol 2002 Nov;13(11):1819-25 7 Citations |
1 | Efficacy of the farnesyl transferase inhibitor R115777 in chronic myeloid leukemia and other hematologic malignancies. (Cortes J, Albitar M, Thomas D, Giles F, Kurzrock R, Thibault A, Rackoff W, Koller C, O'Brien S, Garcia-Manero G, Talpaz M, Kantarjian H) Blood 2003 Mar 01;101(5):1692-7 215 Citations |
1 | Use of epoetin in patients with cancer: evidence-based clinical practice guidelines of the American Society of Clinical Oncology and the American Society of Hematology. (Rizzo JD, Lichtin AE, Woolf SH, Seidenfeld J, Bennett CL, Cella D, Djulbegovic B, Goode MJ, Jakubowski AA, Lee SJ, Miller CB, Rarick MU, Regan DH, Browman GP, Gordon MS, American Society of Clinical Oncology, Americcan Society of Hematology) Blood 2002 Oct 01;100(7):2303-20 204 Citations |
1 | Infliximab retreatment in adults and children with Crohn's disease: risk factors for the development of delayed severe systemic reaction. (Kugathasan S, Levy MB, Saeian K, Vasilopoulos S, Kim JP, Prajapati D, Emmons J, Martinez A, Kelly KJ, Binion DG) Am J Gastroenterol 2002 Jun;97(6):1408-14 122 Citations |
1 | Infantile hemangioma: clinical resolution with 5% imiquimod cream. (Martinez MI, Sanchez-Carpintero I, North PE, Mihm MC Jr) Arch Dermatol 2002 Jul;138(7):881-4; discussion 884 103 Citations |
1 | Use of recombinant factor IX in subjects with haemophilia B undergoing surgery. (Ragni MV, Pasi KJ, White GC, Giangrande PL, Courter SG, Tubridy KL, Recombinant FIX Surgical Study Group) Haemophilia 2002 Mar;8(2):91-7 63 Citations |
1 | Randomized trial of cisplatin and ifosfamide with or without bleomycin in squamous carcinoma of the cervix: a gynecologic oncology group study. (Bloss JD, Blessing JA, Behrens BC, Mannel RS, Rader JS, Sood AK, Markman M, Benda J) J Clin Oncol 2002 Apr 01;20(7):1832-7 119 Citations |
1 | Phase II trial of pyrazoloacridine in patients with persistent or recurrent endometrial carcinoma: a Gynecologic Oncology Group Study. (Plaxe SC, Blessing JA, Husseinzadeh N, Webster KD, Rader JS, Dunton CJ) Gynecol Oncol 2002 Feb;84(2):241-4 19 Citations |
1 | Pilot study of low-dose interleukin-11 in patients with bone marrow failure. (Kurzrock R, Cortes J, Thomas DA, Jeha S, Pilat S, Talpaz M) J Clin Oncol 2001 Nov 01;19(21):4165-72 61 Citations |
1 | Combining gemcitabine with radiation in pancreatic cancer: understanding important variables influencing the therapeutic index. (Crane CH, Wolff RA, Abbruzzese JL, Evans DB, Milas L, Mason K, Charnsangavej C, Pisters PW, Lee JE, Lenzi R, Lahoti S, Vauthey JN, Janjan NA) Semin Oncol 2001 Jun;28(3 Suppl 10):25-33 57 Citations |
1 | Fludarabine and cytarabine as a sequential infusion regimen for treatment of adults with recurrent, refractory or poor prognosis acute leukemia. (Vidarsson B, Abonour R, Williams EC, Woodson RD, Turman NJ, Kim K, Mosher DF, Wiersma SR, Longo WL) Leuk Lymphoma 2001 Apr;41(3-4):321-31 18 Citations |
1 | Phase I study of chimeric human/murine anti-ganglioside G(D2) monoclonal antibody (ch14.18) with granulocyte-macrophage colony-stimulating factor in children with neuroblastoma immediately after hematopoietic stem-cell transplantation: a Children's Cancer Group Study. (Ozkaynak MF, Sondel PM, Krailo MD, Gan J, Javorsky B, Reisfeld RA, Matthay KK, Reaman GH, Seeger RC) J Clin Oncol 2000 Dec 15;18(24):4077-85 167 Citations |
1 | K(ATP) channels mediate the beneficial effects of chronic ethanol ingestion. (Pagel PS, Toller WG, Gross ER, Gare M, Kersten JR, Warltier DC) Am J Physiol Heart Circ Physiol 2000 Nov;279(5):H2574-9 39 Citations |
1 | Acute orthostatic hypotension when starting dopamine agonists in Parkinson's disease. (Kujawa K, Leurgans S, Raman R, Blasucci L, Goetz CG) Arch Neurol 2000 Oct;57(10):1461-3 121 Citations |
1 | Norethindrone acetate and estradiol-induced endometrial hyperplasia. (Kurman RJ, Félix JC, Archer DF, Nanavati N, Arce J, Moyer DL) Obstet Gynecol 2000 Sep;96(3):373-9 63 Citations |
1 | Chronic propranolol induces deficits in retention but not acquisition performance in the water maze in mice. (Czech DA, Nielson KA, Laubmeier KK) Neurobiol Learn Mem 2000 Jul;74(1):17-26 18 Citations |
1 | Induction characteristics with 3% and 8% sevoflurane in adults: an evaluation of the second stage of anaesthesia and its haemodynamic consequences. (Hall JE, Ebert TJ, Harmer M) Anaesthesia 2000 Jun;55(6):545-50 18 Citations |
2 | Patterns, correlates, and barriers to medication adherence among persons prescribed new treatments for HIV disease. (Catz SL, Kelly JA, Bogart LM, Benotsch EG, McAuliffe TL) Health Psychol 2000 Mar;19(2):124-33 588 Citations |
1 | Randomized trial of candesartan cilexetil in the treatment of patients with congestive heart failure and a history of intolerance to angiotensin-converting enzyme inhibitors. (Granger CB, Ertl G, Kuch J, Maggioni AP, McMurray J, Rouleau JL, Stevenson LW, Swedberg K, Young J, Yusuf S, Califf RM, Bart BA, Held P, Michelson EL, Sellers MA, Ohlin G, Sparapani R, Pfeffer MA) Am Heart J 2000 Apr;139(4):609-17 108 Citations |
1 | Ibuprofen use to reduce the incidence and severity of bronchopulmonary dysplasia: a pilot study. (Raju NV, Bharadwaj RA, Thomas R, Konduri GG) J Perinatol 2000;20(1):13-6 22 Citations |
1 | Phase II evaluation of interferon-alpha-2a for progressive or recurrent craniopharyngiomas. (Jakacki RI, Cohen BH, Jamison C, Mathews VP, Arenson E, Longee DC, Hilden J, Cornelius A, Needle M, Heilman D, Boaz JC, Luerssen TG) J Neurosurg 2000 Feb;92(2):255-60 58 Citations |
1 | Evaluation of gemcitabine in patients with squamous cell carcinoma of the cervix: a Phase II study of the gynecologic oncology group. (Schilder RJ, Blessing JA, Morgan M, Mangan CE, Rader JS) Gynecol Oncol 2000 Feb;76(2):204-7 83 Citations |
1 | Enhanced staging and all chemotherapy preoperatively in patients with potentially resectable gastric carcinoma. (Ajani JA, Mansfield PF, Lynch PM, Pisters PW, Feig B, Dumas P, Evans DB, Raijman I, Hargraves K, Curley S, Ota DM) J Clin Oncol 1999 Aug;17(8):2403-11 91 Citations |
1 | Dose-intensification of procarbazine, CCNU (lomustine), vincristine (PCV) with peripheral blood stem cell support in young patients with gliomas. (Jakacki RI, Jamison C, Mathews VP, Heilman DK, Dropcho E, Cornetta K, Macdonald DR, Williams DA) Med Pediatr Oncol 1998 Dec;31(6):483-90 20 Citations |
1 | Safeguarding the administration of high-dose chemotherapy: a national practice survey by the American Society for Blood and Marrow Transplantation. (Chen CS, Seidel K, Armitage JO, Fay JW, Appelbaum FR, Horowitz MM, Shpall EJ, Weiden PL, Antman KS, Champlin RE, Kersey JH, Sullivan KM) Biol Blood Marrow Transplant 1997 Dec;3(6):331-40 19 Citations |
1 | Topotecan in platinum- and paclitaxel-resistant ovarian cancer. (Swisher EM, Mutch DG, Rader JS, Elbendary A, Herzog TJ) Gynecol Oncol 1997 Sep;66(3):480-6 146 Citations |
1 | Estrogen-progestin replacement therapy and endometrial cancer. (Pike MC, Peters RK, Cozen W, Probst-Hensch NM, Felix JC, Wan PC, Mack TM) J Natl Cancer Inst 1997 Aug 06;89(15):1110-6 288 Citations |
1 | Hemodynamic effects of repetitive cocaine administration. (Pagel PS, Warltier DC) Circulation 1997 Aug 05;96(3):1050 |
1 | One-day cold perfusion of bimakalim and butanedione monoxime restores ex situ cardiac function. (Stowe DF, Graf BM, Fujita S, Gross GJ) Am J Physiol 1996 Nov;271(5 Pt 2):H1884-92 12 Citations |
1 | Treatment of donor mice with an alpha beta T-cell receptor monoclonal antibody induces prolonged T-cell nonresponsiveness and effectively prevents lethal graft-versus-host disease in murine recipients of major histocompatibility complex (MHC)-matched and MHC-mismatched donor marrow grafts. (Drobyski WR, Majewski D) Blood 1996 Jun 15;87(12):5355-69 11 Citations |
1 | The accuracy of medication data in an outpatient electronic medical record. (Wagner MM, Hogan WR) J Am Med Inform Assoc 1996;3(3):234-44 99 Citations |
1 | Alternate-day steroid dosing improves growth without adversely affecting graft survival or long-term graft function. A report of the North American Pediatric Renal Transplant Cooperative Study. (Jabs K, Sullivan EK, Avner ED, Harmon WE) Transplantation 1996 Jan 15;61(1):31-6 120 Citations |
2 | Hepatic hemangioendothelioma: successful treatment with steroid in a very-low-birth-weight infant. (Wu TJ, Teng RJ, Tsou Yau KI) Zhonghua Min Guo Xiao Er Ke Yi Xue Hui Za Zhi 1996;37(1):56-8 8 Citations |
1 | Phase I trial of simultaneous administration of interleukin 2 and interleukin 4 subcutaneously. (Whitehead RP, Friedman KD, Clark DA, Pagani K, Rapp L) Clin Cancer Res 1995 Oct;1(10):1145-52 14 Citations |
1 | Prolonged stimulation of intrarenal V1 vasopressin receptors results in sustained hypertension. (Szczepanska-Sadowska E, Stepniakowski K, Skelton MM, Cowley AW Jr) Am J Physiol 1994 Nov;267(5 Pt 2):R1217-25 40 Citations |
1 | Systemic and coronary hemodynamic effects of repetitive cocaine administration in conscious dogs. (Pagel PS, Tessmer JP, Warltier DC) J Cardiovasc Pharmacol 1994 Sep;24(3):443-53 13 Citations |
1 | Combined daily therapy with intravenous ganciclovir and foscarnet for patients with recurrent cytomegalovirus retinitis. (Weinberg DV, Murphy R, Naughton K) Am J Ophthalmol 1994 Jun 15;117(6):776-82 19 Citations |
1 | Hydroxyethyl starch deferoxamine, a novel iron chelator, delays diabetes in BB rats. (Roza AM, Slakey DP, Pieper GM, Van Ye TM, Moore-Hilton G, Komorowski RA, Johnson CP, Hedlund BE, Adams MB) J Lab Clin Med 1994 Apr;123(4):556-60 12 Citations |
1 | Urinary tract infections with low and high colony counts in young women. Spontaneous remission and single-dose vs multiple-day treatment. (Arav-Boger R, Leibovici L, Danon YL) Arch Intern Med 1994 Feb 14;154(3):300-4 52 Citations |
1 | Phase I trial of an oral immunomodulator and interferon inducer in cancer patients. (Witt PL, Ritch PS, Reding D, McAuliffe TL, Westrick L, Grossberg SE, Borden EC) Cancer Res 1993 Nov 01;53(21):5176-80 78 Citations |
1 | Effect of single and repeated doses of metoclopramide on the mechanisms of gastroesophageal reflux. (Durazo FA, Valenzuela JE) Am J Gastroenterol 1993 Oct;88(10):1657-62 13 Citations |
1 | Effects of chronic nicotine treatment on the accumulation of [3H]tetraphenylphosphonium by cerebral cortical synaptosomes. (Hillard CJ, Pounds JJ) J Neurochem 1993 Feb;60(2):687-95 12 Citations |
1 | Risk of ventricular dysrhythmias during 1-hour infusions of amphotericin B in patients with preserved renal function. (Bowler WA, Weiss PJ, Hill HE, Hoffmeister KA, Fleck RP, Blacky AR, Oldfield EC 3rd) Antimicrob Agents Chemother 1992 Nov;36(11):2542-3 18 Citations |
1 | Rapid suppression of spontaneous ventricular arrhythmias during oral amiodarone loading. (Kim SG, Mannino MM, Chou R, Roth S, Roth JA, Desai B, Ferrick KJ, Fisher JD) Ann Intern Med 1992 Aug 01;117(3):197-201 4 Citations |
1 | Twice-daily tapering dexamethasone treatment during cranial radiation for newly diagnosed brain metastases. (Weissman DE, Janjan NA, Erickson B, Wilson FJ, Greenberg M, Ritch PS, Anderson T, Hansen RM, Chitambar CR, Lawton CA) J Neurooncol 1991 Dec;11(3):235-9 42 Citations |
1 | Phase I study of recombinant human interleukin-3 in patients with bone marrow failure. (Kurzrock R, Talpaz M, Estrov Z, Rosenblum MG, Gutterman JU) J Clin Oncol 1991 Jul;9(7):1241-50 131 Citations |
1 | Bupropion. (Harsch HH) Am Fam Physician 1991 Jun;43(6):1947-50, 1952 |
1 | Effects of low doses of recombinant human granulocyte-macrophage colony stimulating factor (GM-CSF) in patients with myelodysplastic syndromes. (Estey EH, Kurzrock R, Talpaz M, McCredie KB, O'Brien S, Kantarjian HM, Keating MJ, Deisseroth AB, Gutterman JU) Br J Haematol 1991 Mar;77(3):291-5 73 Citations |
1 | Prevention of salt angiotensin II hypertension by servo control of body water. (Krieger JE, Cowley AW Jr) Am J Physiol 1990 Apr;258(4 Pt 2):H994-1003 32 Citations |
1 | [D-Ala2,Leu5,Cys6]enkephalin: short-term agonist effects and long-term antagonism at delta opioid receptors. (Calcagnetti DJ, Fanselow MS, Helmstetter FJ, Bowen WD) Peptides 1989;10(2):319-26 27 Citations |
1 | Multicenter, double-blind, multiple-dose, parallel-groups efficacy and safety trial of azelastine, chlorpheniramine, and placebo in the treatment of spring allergic rhinitis. (Weiler JM, Donnelly A, Campbell BH, Connell JT, Diamond L, Hamilton LH, Rosenthal RR, Hemsworth GR, Perhach JL Jr) J Allergy Clin Immunol 1988 Nov;82(5 Pt 1):801-11 36 Citations |
1 | Low-dose aspirin protects against lipid accumulation in primate vein bypass grafts. (Boerboom LE, Olinger GN, Kissebah AH, Montgomery RR) J Thorac Cardiovasc Surg 1987 Aug;94(2):251-5 8 Citations |
1 | Phase I study of i.v. administered recombinant gamma interferon in cancer patients. (Kurzrock R, Quesada JR, Rosenblum MG, Sherwin SA, Gutterman JU) Cancer Treat Rep 1986 Dec;70(12):1357-64 35 Citations |
1 | An overnight high-dose dexamethasone suppression test for rapid differential diagnosis of Cushing's syndrome. (Tyrrell JB, Findling JW, Aron DC, Fitzgerald PA, Forsham PH) Ann Intern Med 1986 Feb;104(2):180-6 135 Citations |
1 | Once-daily vs. continuous aminoglycoside dosing: efficacy and toxicity in animal and clinical studies of gentamicin, netilmicin, and tobramycin. (Powell SH, Thompson WL, Luthe MA, Stern RC, Grossniklaus DA, Bloxham DD, Groden DL, Jacobs MR, DiScenna AO, Cash HA, Klinger JD) J Infect Dis 1983 May;147(5):918-32 252 Citations |